scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Mohamed Jaber | Q47706873 |
Marc Caron | Q64858849 | ||
P2093 | author name string | C Missale | |
S W Robinson | |||
S R Nash | |||
P2860 | cites work | Dopaminergic Control of Plasma Catecholamine and Aldosterone Responses to Acute Stimuli in Normal Man | Q72865580 |
Dopamine neuron membrane physiology: characterization of the transient outward current (IA) and demonstration of a common signal transduction pathway for IA and IK | Q72887110 | ||
Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats | Q72966588 | ||
SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE | Q76623887 | ||
Functional interactions between D-1 and D-2 dopamine receptor systems: their role in the regulation of psychomotor behaviour, putative mechanisms, and clinical relevance | Q82885595 | ||
The d-1 dopamine receptor and the search for its functional role: from neurochemistry to behaviour | Q84076732 | ||
Dopamine receptor subtypes in renal brush border and basolateral membranes | Q93520179 | ||
Microfilaments and the effects of antidiuretic hormone on water permeability | Q93605869 | ||
Dopaminergic inhibition of the action of vasopressin on the cortical collecting tubule | Q93646850 | ||
Molecular cloning and expression of the gene for a human D1 dopamine receptor | Q24298197 | ||
Cloning and expression of human and rat D1 dopamine receptors | Q24306738 | ||
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter | Q24310836 | ||
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 | Q24313045 | ||
Functional expression and characterization of human D2 and D3 dopamine receptors | Q24318801 | ||
Dopamine D4 receptors elevated in schizophrenia | Q24318936 | ||
Functional expression of human D3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells | Q24319600 | ||
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine | Q24319813 | ||
Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor | Q24321094 | ||
Pharmacology of high-threshold calcium currents in GH4C1 pituitary cells and their regulation by activation of human D2 and D4 dopamine receptors | Q24321558 | ||
Chimeric D2/D3 dopamine receptors efficiently inhibit adenylyl cyclase in HEK 293 cells | Q24323016 | ||
Multiple dopamine D4 receptor variants in the human population | Q24336675 | ||
Differential sensitivity of the short and long human dopamine D2 receptor subtypes to protein kinase C | Q24337480 | ||
Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum | Q24557423 | ||
Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes | Q24560472 | ||
Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin | Q24564132 | ||
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics | Q28258681 | ||
Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour | Q72142542 | ||
Dopaminergic modulation of aldosterone secretion is independent of alterations in renin secretion | Q72148425 | ||
Differential coupling of D1 and D5 dopamine receptors to guanine nucleotide binding proteins in transfected GH4C1 rat somatomammotrophic cells | Q72169564 | ||
Chronic dopamine D2 receptor activation does not affect survival and differentiation of cultured dopaminergic neurons: morphological and neurochemical observations | Q72207609 | ||
Dopamine D4 receptor polymorphism and schizophrenia | Q72212921 | ||
Grooming and vacuous chewing induced by SK&F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase | Q72216163 | ||
Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation | Q72216922 | ||
D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain | Q72244610 | ||
Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra | Q72254053 | ||
The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity | Q72296913 | ||
Increased urinary dopamine excretion in young patients with essential hypertension | Q72312692 | ||
Dopamine-modulated potassium channels on rat striatal neurons: specific activation and cellular expression | Q72334909 | ||
Further evidence of no linkage between schizophrenia and the dopamine D3 receptor gene locus | Q72382842 | ||
The Dopamine Receptor in the Intermediate Lobe of the Rat Pituitary Gland: Pharmacological Characterization | Q72433473 | ||
Characterization with 3H-haloperidol of the dopamine receptor in the rat kidney particulate preparation | Q72476437 | ||
Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride | Q72557746 | ||
Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons | Q72558033 | ||
Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro | Q72572291 | ||
Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297 | Q72589455 | ||
Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist | Q72637266 | ||
Dopamine D1 receptor family agonists, SK&F38393, SK&F77434, and SK&F82958, differentially affect locomotor activities in rats | Q72661063 | ||
Dopamine blocks T-type calcium channels in cultured rat adrenal glomerulosa cells | Q72662927 | ||
Dopamine is taken up from the circulation by, and released from, local noradrenergic varicose axon terminals in zona glomerulosa of the rat: a neurochemical and immunocytochemical study | Q72773978 | ||
Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists | Q72806301 | ||
Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens | Q72861039 | ||
Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain | Q28276882 | ||
Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations | Q28306686 | ||
Reserpine treatment stimulates enkephalin and D2 dopamine receptor gene expression in the rat striatum | Q28326963 | ||
A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons | Q28368794 | ||
Depression of high-threshold calcium currents by activation of human D2 (short) dopamine receptors expressed in differentiated NG108-15 cells | Q28369308 | ||
Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity | Q28369508 | ||
Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents | Q28564581 | ||
Cloning and expression of a rat D2 dopamine receptor cDNA | Q28567326 | ||
Dopamine D1A receptor regulation of phospholipase C isoform | Q28577724 | ||
Altered striatal function in a mutant mouse lacking D1A dopamine receptors | Q28585357 | ||
Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses | Q28585702 | ||
Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors | Q28587334 | ||
Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice | Q28591400 | ||
Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins | Q28592318 | ||
Cloning of the cDNA and gene for a human D2 dopamine receptor | Q28645687 | ||
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats | Q30448966 | ||
Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans | Q30448972 | ||
Persistent defective coupling of dopamine-1 receptors to G proteins after solubilization from kidney proximal tubules of hypertensive rats | Q30449320 | ||
Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension | Q30449406 | ||
Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine | Q30449512 | ||
Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat | Q30449828 | ||
Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone | Q30449867 | ||
Dopamine DA-2 receptor sites in the rat renal cortex: a light microscope autoradiographic study | Q33324317 | ||
Association between schizophrenia and homozygosity at the dopamine D3 receptor gene | Q33594750 | ||
Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine | Q33610933 | ||
Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation | Q33769329 | ||
Autoradiographic localization of dopamine DA-1 receptors in the rat renal vasculature using [3H]-SCH 23390 as a ligand | Q33879386 | ||
Intracellular signaling in the regulation of renal Na-K-ATPase. II. Role of eicosanoids | Q33888717 | ||
Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C. | Q33924735 | ||
EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW | Q33956745 | ||
Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids. | Q34010145 | ||
Prostaglandin E2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium | Q34264665 | ||
Distribution of D2 dopamine receptor mRNA in rat brain | Q34309246 | ||
Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary | Q48153031 | ||
Opposing actions of D1- and D2-dopamine receptors on arachidonic acid release and cyclic AMP production in striatal neurons. | Q48164574 | ||
Anatomical study of enkephalin gene expression in the rat forebrain following haloperidol treatment | Q48169738 | ||
Methamphetamine-induced changes in the striatal-nigral dynorphin system: role of D-1 and D-2 receptors | Q48179887 | ||
The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task | Q48185891 | ||
Alternative transcripts of the rat and human dopamine D3 receptor | Q48204023 | ||
Heterogeneous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum | Q48249521 | ||
Modulation of cocaine self-administration in the rat through D-3 dopamine receptors | Q48266278 | ||
Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system | Q48274936 | ||
D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. | Q48287056 | ||
Dopamine D3 receptor mRNA and binding sites in human brain. | Q48316464 | ||
Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. | Q48323891 | ||
Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. | Q48342248 | ||
Behavioural evidence for "D-1-like" dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C. | Q48389940 | ||
Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways | Q48392233 | ||
Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin | Q48396113 | ||
D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease | Q48427737 | ||
Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum. | Q48428539 | ||
Inhibition of inositol phospholipid breakdown by D2 dopamine receptors in dissociated bovine anterior pituitary cells. | Q48445738 | ||
Differential G protein-mediated coupling of D2 dopamine receptors to K+ and Ca2+ currents in rat anterior pituitary cells | Q48524605 | ||
Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine | Q48594909 | ||
Dopamine and the pharmacology of schizophrenia: the state of the evidence. | Q48606507 | ||
D2 dopamine receptor activation of potassium channels in identified rat lactotrophs: whole-cell and single-channel recording | Q48620830 | ||
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. | Q48623758 | ||
Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: Comparison with basic fibroblast growth factor | Q48629557 | ||
Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors. | Q48649089 | ||
Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine release. | Q48699137 | ||
Localized intracaudate dopamine D2 receptor activation during the post-training period improves memory for visual or olfactory conditioned emotional responses in rats. | Q48736277 | ||
Dopamine receptors mediating inhibition of the cyclic adenosine monophosphate generating system in the rat renal cortex | Q48763689 | ||
Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. | Q48763703 | ||
Effects of dopamine on voltage-dependent potassium currents in identified rat lactotroph cells. | Q48848186 | ||
Further evidence against the coupling of dopamine receptors to phosphoinositide hydrolysis in rat striatum. | Q48951339 | ||
Synaptic modulation by dopamine of calcium currents in rat pars intermedia. | Q49081814 | ||
Reward and detection thresholds for brain stimulation: dissociative effects of cocaine. | Q49128638 | ||
Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices. | Q51676849 | ||
A dopaminergic inhibitory postsynaptic potential mediated by an increased potassium conductance. | Q51760758 | ||
Modulation of adrenal catecholamine release by DA2 dopamine receptors in the anaesthetized dog. | Q51769593 | ||
D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. | Q52015952 | ||
Site-directed mutagenesis of the human dopamine D2 receptor | Q52041433 | ||
Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys. | Q52053207 | ||
Lack of renal dopamine production during acute volume expansion in Dahl salt-sensitive rats. | Q54211970 | ||
DIRECT RENAL VASODILATATION PRODUCED BY DOPAMINE IN THE DOG. | Q54325949 | ||
Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro. | Q54425144 | ||
Dopaminergic mediation of the diuretic and natriuretic effects of ANF in the rat. | Q54426456 | ||
Dopamine stimulates K+ efflux in the chick retina via D1 receptors independently of adenylyl cyclase activation. | Q54697372 | ||
Alternative splicing directs the expression of two D2 dopamine receptor isoforms. | Q55058608 | ||
Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors. | Q55066633 | ||
Analysis of the D4 Dopamine Receptor Gene Variant in an Italian Schizophrenia Kindred | Q57016573 | ||
Activation of facilitation calcium channels in chromaffin cells by D1 dopamine receptors through a cAMP/protein kinase A-dependent mechanism | Q59065349 | ||
Striatal c-fos Induction by Cocaine or Apomorphine Occurs Preferentially in Output Neurons Projecting to the Substantia Nigra in the Rat | Q59574904 | ||
Five years' experience with gamma-L-glutamyl-L-dopa: a relatively renally specific dopaminergic prodrug in man. | Q37835277 | ||
Multiple receptors for dopamine | Q37876912 | ||
A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development | Q37918975 | ||
Dopamine receptor subtypes: beyond the D1/D2 classification | Q37946158 | ||
Full-length cDNA cloning and distribution of human dopamine D4 receptor | Q38298291 | ||
Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing | Q38335214 | ||
Receptor subtype-specific dopaminergic agents and conditioned behavior | Q38366637 | ||
This is not a G protein-coupled receptor. | Q38513267 | ||
Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist | Q38692046 | ||
Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia. | Q38755328 | ||
Acute Dopaminergic Inhibition of Aldosterone Secretion Is Independent of Angiotensin II and Adrenocorticotropin* | Q38932089 | ||
Dopamine: a prolactin-inhibiting hormone | Q39409725 | ||
D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications | Q39487630 | ||
A Comparison of the Vascular Dopamine Receptor with Other Dopamine Receptors | Q39722906 | ||
Metabolic substrates, cellular energy production, and the regulation of proximal tubular transport | Q39819717 | ||
Biochemical and Physiological Studies of the Beta-Adrenoceptor and the D-2 Dopamine Receptor in the Intermediate Lobe of the Rat Pituitary Gland: A Review | Q40131545 | ||
Bromocriptine-induced modulation of plasma aldosterone response to acute stimulations | Q40242046 | ||
Dopamine and the kidney | Q40264312 | ||
Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. | Q40368111 | ||
Novel dopamine receptors half a decade later | Q40372450 | ||
Acute and Chronic Nicotinic Interactions with Dopamine Systems and Working Memory Performancea | Q40444475 | ||
Renal dopamine and the tubular handling of sodium. | Q40449489 | ||
The role of dopamine in drug abuse viewed from the perspective of its role in motivation. | Q40480641 | ||
Role of the nucleus accumbens and the striatum in the production of turning behaviour in intact rats | Q40494298 | ||
Structure/function studies of mammalian Na-H exchangers--an update. | Q40513978 | ||
Phosphaturic effect of dopamine in dogs. Possible role of intrarenally produced dopamine in phosphate regulation | Q40528910 | ||
Dopamine receptors: molecular biology, biochemistry and behavioural aspects | Q40604994 | ||
Memory enhancement by post-training peripheral administration of low doses of dopamine agonists: possible autoreceptor effect | Q40710310 | ||
Dopaminergic defect in hypertension | Q40725885 | ||
Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins | Q40784172 | ||
Multiple control of calcium channel gating by dopamine D2 receptors in frog pituitary melanotrophs | Q40855139 | ||
Structures of dopamine receptors | Q40878399 | ||
Recent advances in the molecular biology of dopamine receptors | Q40890829 | ||
Molecular diversity of the dopamine receptors | Q40908177 | ||
An evolutionary view of drug-receptor interaction: the bioamine receptor family | Q40956801 | ||
Analysis of new D4 dopamine receptor (DRD4) coding region variants and TH microsatellite in the Old Order Amish family (OOA110). | Q41053667 | ||
Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors | Q41086120 | ||
D2 dopamine receptor localization on striatonigral neurons | Q41107675 | ||
Increased Dopamine-Induced Nephrogenous cAMP Formation in Hypertension | Q41130244 | ||
No linkage between D2 dopamine receptor gene region and schizophrenia | Q41190005 | ||
Localization of dopamine D4 receptors in GABAergic neurons of the primate brain | Q41198273 | ||
Role of kidney dopamine in the natriuretic response to volume expansion in rats | Q41294057 | ||
Coupling of human D-1 dopamine receptors to different guanine nucleotide binding proteins. Evidence that D-1 dopamine receptors can couple to both Gs and G(o). | Q41334451 | ||
Mechanisms of dopamine effects on Na-K-ATPase activity in Madin-Darby canine kidney (MDCK) epithelial cells | Q41356827 | ||
A dopamine-responsive domain in the N-terminal sequence of Pit-1. Transcriptional inhibition in endocrine cell types | Q41357884 | ||
The dopamine D1D receptor. Cloning and characterization of three pharmacologically distinct D1-like receptors from Gallus domesticus | Q41368040 | ||
Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells | Q41383169 | ||
Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line | Q41454950 | ||
Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas | Q41461238 | ||
Expression and functional characterisation of a synthetic version of the human D4 dopamine receptor in a stable human cell line | Q41466686 | ||
Characteristics of stably expressed human dopamine D1a and D1b receptors: atypical behavior of the dopamine D1b receptor. | Q41480479 | ||
Epidermal growth factor treatment induces D2 dopamine receptors functionally coupled to delayed outward potassium current (IK) in GH4C1 clonal anterior pituitary cells | Q41499405 | ||
Characterization of the human dopamine D3 receptor expressed in transfected cell lines | Q41503118 | ||
Differences in the ligand binding properties of the short and long versions of the D2 dopamine receptor | Q41582101 | ||
Contributions of Conserved Serine Residues to the Interactions of Ligands with Dopamine D2 Receptors | Q41612608 | ||
Dopamine inhibits Na/K-ATPase in single tubules and cultured cells from distal nephron | Q41616921 | ||
Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture | Q41643841 | ||
Histofluorescence techniques provide evidence for dopamine-containing neuronal elements in canine kidney | Q41653168 | ||
D1Dopamine Receptors Can Interact with Both Stimulatory and Inhibitory Guanine Nucleotide Binding Proteins | Q41662794 | ||
Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism | Q41665525 | ||
Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. | Q41675749 | ||
Diminished phospholipase C activation by dopamine in spontaneously hypertensive rats | Q41941872 | ||
Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor | Q42109345 | ||
Effect of reserpine treatment on enkephalin mRNA level in the rat striatum: an in situ hybridization study | Q42274723 | ||
Effects of dopamine, high potassium concentration and field stimulation on the secretion of aldosterone by the perfused rat adrenal gland | Q42461391 | ||
The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine | Q42465119 | ||
Dopamine actions on calcium currents, potassium currents and hormone release in rat melanotrophs | Q42467159 | ||
Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells. | Q42480320 | ||
The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture | Q42497537 | ||
Dopamine regulation of renal Na+,K(+)-ATPase activity is lacking in Dahl salt-sensitive rats | Q42497728 | ||
Resistance to bromocriptine in prolactinomas | Q42499170 | ||
G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase | Q42511423 | ||
Electrophysiological responses to dopamine of rat hypophysial cells in lactotroph-enriched primary cultures | Q42520216 | ||
Nonlinkage of bipolar illness to tyrosine hydroxylase, tyrosinase, and D2 and D4 dopamine receptor genes on chromosome 11. | Q42692501 | ||
Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues | Q43514176 | ||
Identification and characterization of postsynaptic D1- and D2-dopamine receptors in the cardiovascular system | Q43701851 | ||
Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment | Q43990326 | ||
Relationship between the Adrenergic Nervous System and Renin during Adaptation to Upright Posture: A Possible Role for 3,4-Dihydroxyphenethylamine (Dopamine) | Q44100932 | ||
Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure | Q44137317 | ||
Distribution of D5 dopamine receptor mRNA in rat brain | Q44144250 | ||
Binding of [3H]SCH23390 to a non-dopaminergic site in bovine kidney | Q44199678 | ||
Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitylated | Q44241904 | ||
D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons | Q44243782 | ||
Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study | Q44341091 | ||
Dopamine receptors on adrenal chromaffin cells modulate calcium uptake and catecholamine release | Q44423158 | ||
Dopamine D1 receptor mRNA in rat kidney: localization byin situhybridization | Q44812115 | ||
Renal tubular reabsorption of sodium and water during infusion of low-dose dopamine in normal man. | Q45056953 | ||
Exclusion of linkage between schizophrenia and the D2 dopamine receptor gene region of chromosome 11q in 112 Irish multiplex families | Q45093654 | ||
Enhanced dopamine renal responsiveness in patients with hypertension | Q45175164 | ||
Potassium channels involved in the transduction mechanism of dopamine D2 receptors in rat lactotrophs | Q45191194 | ||
D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory | Q45191426 | ||
Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro | Q45719561 | ||
Quantitative in situ hybridization evidence for differential regulation of proenkephalin and dopamine D2 receptor mRNA levels in the rat striatum: effects of unilateral intrastriatal injections of 6-hydroxydopamine | Q45918593 | ||
A genetic linkage study of bipolar disorder and 13 markers on chromosome 11 including the D2 dopamine receptor | Q46358117 | ||
Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism | Q46780322 | ||
Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action | Q47818715 | ||
Epidermal growth factor and basic fibroblast growth factor have independent actions on mesencephalic dopamine neurons in culture. | Q48109545 | ||
Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. | Q48136063 | ||
Bilateral intra-accumbens self-administration of d-amphetamine: antagonism with intra-accumbens SCH-23390 and sulpiride | Q48152478 | ||
Dopamine- and cAMP-regulated phosphoprotein (DARPP-32) and dopamine DA1 agonist-sensitive Na+,K+-ATPase in renal tubule cells | Q34313695 | ||
Dopamine receptor pharmacology | Q34324458 | ||
Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists | Q34374970 | ||
Characterization of subtype-specific antibodies to the human D5 dopamine receptor: studies in primate brain and transfected mammalian cells | Q34445682 | ||
Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. | Q34463968 | ||
Brain dopamine and reward | Q34498922 | ||
Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension | Q34517881 | ||
Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia | Q34661211 | ||
Morphogenic potentials of D2, D3, and D4 dopamine receptors revealed in transfected neuronal cell lines | Q34990899 | ||
Multiple D2 dopamine receptors produced by alternative RNA splicing | Q35164518 | ||
Sequence alignment of the G-protein coupled receptor superfamily | Q35225323 | ||
Receptor subtypes in opioid and stimulant reward | Q35232156 | ||
New classes of selective D-1 dopamine receptor antagonist provide further evidence for two directions of D-1:D-2 interaction | Q35281982 | ||
The neostriatal mosaic: multiple levels of compartmental organization | Q35318347 | ||
Dopamine receptor interactions: some implications for the treatment of Parkinson's disease | Q35327584 | ||
D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines | Q35528206 | ||
Reward and abuse of opiates | Q35531099 | ||
Intracellular signaling in the regulation of renal Na-K-ATPase. I. Role of cyclic AMP and phospholipase A2 | Q35601970 | ||
Anterior pituitary development: short tales from dwarf mice | Q35721320 | ||
D1A, D1B, and D1C dopamine receptors from Xenopus laevis | Q35861028 | ||
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas | Q36081822 | ||
Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary | Q36376360 | ||
Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia | Q36495589 | ||
Nerve growth factor suppresses the transforming phenotype of human prolactinomas | Q36501758 | ||
The Mechanism of Action of Novel Antipsychotic Drugs | Q36515345 | ||
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies | Q36558137 | ||
Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors | Q36714587 | ||
Pharmacological characterization and autoradiographic localization of dopamine receptors in the human adrenal cortex | Q36735006 | ||
Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine | Q37000403 | ||
Dopamine receptor subtypes colocalize in rat striatonigral neurons | Q37270387 | ||
Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus | Q37346892 | ||
Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase | Q37350486 | ||
D1 and D2 dopamine receptor mRNA in rat brain | Q37419023 | ||
D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum | Q61762612 | ||
Behavioral correlations of dopamine receptor activation | Q64764337 | ||
Suppressed dopaminergic activity and water-sodium handling in the kidneys at the prehypertensive stage of essential hypertension | Q67236962 | ||
Derivation of urinary dopamine from plasma dopa | Q67255449 | ||
Dopamine-containing vasomotor nerves in the dog kidney | Q67356461 | ||
High salt diet down‐regulates proximal tubule Na+, K+‐ATPase activity in Dahl salt‐resistant but not in Dahl salt‐sensitive rats: evidence of defective dopamine regulation | Q67488457 | ||
Linkage analysis of the D1 dopamine receptor gene and manic depression in six families | Q67524667 | ||
Mechanisms involved in the interaction of dopamine with angiotensin II on aldosterone secretion in isolated and cultured rat adrenal glomerulosa cells | Q67907102 | ||
Expression of functional D2 dopamine receptors following differentiation of Y-79 human retinoblastoma cells | Q68084570 | ||
Renal dopamine and sodium excretion | Q68093236 | ||
Endogenous dopamine (DA) and DA2 receptors: a mechanism limiting excessive sympathetic-adrenal discharge in humans | Q68130463 | ||
Localization of dopamine-1 receptors along the microdissected rat nephron | Q68265742 | ||
Expression of dopamine D2 receptor and choline acetyltransferase mRNA in the dopamine deafferented rat caudate-putamen | Q68440218 | ||
Autoradiographic localization of vascular dopamine receptors | Q68532933 | ||
Dietary sodium intake and urinary dopamine and sodium excretion during the course of blood pressure development in Dahl salt-sensitive and salt-resistant rats | Q68670496 | ||
Effect of DA1 receptor blockade with SCH 23390 on the renal response to electrical stimulation of the renal nerves | Q68862637 | ||
Urinary dopamine excretion in normotensive subjects with or without family history of hypertension | Q68866175 | ||
Dopamine inhibits the aldosterone response to upright posture | Q68878319 | ||
Characterization of dopamine receptors associated with aldosterone secretion in rat adrenal glomerulosa | Q68908386 | ||
Rat juxtaglomerular cells are endowed with DA-1 dopamine receptors mediating renin release | Q69058122 | ||
Adenosinergic modulation of caffeine-induced c-fos mRNA expression in mouse brain | Q69249724 | ||
Specific binding of 125I SCH 23982, a selective dopamine (D1) receptor ligand to plasma membranes derived from human kidney cortex | Q69296773 | ||
Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats | Q69304549 | ||
Evidence that specific dopamine-1 receptor activation is involved in dopamine-induced renin release | Q69370071 | ||
Effect of apomorphine on adrenal medullary catecholamine levels | Q69378150 | ||
High-affinity uptake of 67Cu into a veratridine-releasable pool in brain tissue | Q69528815 | ||
D2 dopamine receptors on bovine chromaffin cell membranes: identification and characterization by [3H]N-methylspiperone binding | Q69696626 | ||
Dopamine receptors: applications in clinical cardiology | Q69864144 | ||
Dopamine produces forearm vasodilatation following alpha-adrenoceptor blockade by an action on vascular dopamine (DA1) receptors in man | Q69903070 | ||
Dopaminergic modulation of salt sensitivity in patients with essential hypertension | Q70020404 | ||
Inhibition of the aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors | Q70063215 | ||
The effect of dopamine receptor blockade on natriuresis is dependent on the degree of hypervolemia | Q70115264 | ||
Dopamine selectively inhibits aldosterone responses to angiotensin II in humans | Q70137694 | ||
Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockade | Q70148377 | ||
A family of receptors coupled to guanine nucleotide regulatory proteins | Q70185993 | ||
A Paradoxical Fall in Urine Dopamine Output When Patients with Essential Hypertension Are Given Added Dietary Salt | Q70361544 | ||
Dopaminergic suppression of angiotensin II-induced aldosterone secretion in man: differential responses during sodium loading and depletion | Q70369833 | ||
Exclusion of close linkage of Tourette's syndrome to D1 dopamine receptor | Q70564286 | ||
Dopamine D1 receptor mutagenesis: role of amino acids in agonist and antagonist binding | Q70643715 | ||
Dopamine and the kidney: ten years on | Q70680051 | ||
Decreased Plasma and Urinary Dopamine during Dietary Sodium Depletion in Man* | Q70764966 | ||
Tonic dopaminergic suppression of plasma aldosterone | Q71213729 | ||
Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release | Q71358607 | ||
Distribution of dopamine D1, D2, and D5 receptor mRNAs in the monkey brain: ribonuclease protection assay analysis | Q71521102 | ||
Transcription mediated by a cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors | Q37478164 | ||
Characterization of a dopamine receptor (DA2K) in the kidney inner medulla | Q37478566 | ||
Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene | Q37511116 | ||
A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP-mediated arachidonic acid release | Q37557274 | ||
Mesocorticolimbic dopaminergic network: functional and regulatory roles | Q37623119 | ||
Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzyme | Q37647401 | ||
Dopamine receptor gene expression by enkephalin neurons in rat forebrain. | Q37662769 | ||
Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes | Q37720646 | ||
Management of prolactinomas | Q37724270 | ||
Role of dopaminergic mechanisms in the kidney for the pathogenesis of hypertension | Q37803615 | ||
Stimulation of lactotrope differentiation in vitro by fibroblast growth factor | Q71605071 | ||
Differential effects of amphetamine isomers on SN self-stimulation: evidence for DA neuron subtypes | Q71749300 | ||
Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons | Q71899031 | ||
Epidermal growth factor and basic fibroblast growth factor protect dopaminergic neurons from glutamate toxicity in culture | Q71978414 | ||
Selection of alternative G-mediated signaling pathways at the dopamine D2 receptor by protein kinase C | Q72103180 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dopamine | Q170304 |
phospholipase C-activating dopamine receptor signaling pathway | Q15335158 | ||
Dopamine receptor D5 | Q21131500 | ||
P304 | page(s) | 189-225 | |
P577 | publication date | 1998-01-01 | |
P1433 | published in | Physiological Reviews | Q1091827 |
P1476 | title | Dopamine receptors: from structure to function | |
P478 | volume | 78 |
Q28248215 | (-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signaling |
Q34472800 | 4-Phenylbutyrate attenuates the ER stress response and cyclic AMP accumulation in DYT1 dystonia cell models |
Q36334398 | 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen |
Q54621041 | 6-[18F]fluoro-L-DOPA uptake in the rat pancreas is dependent on the tracer metabolism. |
Q28479038 | A "genome-to-lead" approach for insecticide discovery: pharmacological characterization and screening of Aedes aegypti D(1)-like dopamine receptors |
Q47254297 | A Concise Review of the Conflicting Roles of Dopamine-1 versus Dopamine-2 Receptors in Wound Healing. |
Q44419012 | A Critical Role for Nucleus Accumbens Dopamine in Partner-Preference Formation in Male Prairie Voles |
Q34394954 | A Drosophila dopamine 2-like receptor: Molecular characterization and identification of multiple alternatively spliced variants |
Q36736229 | A GIPC1-Palmitate Switch Modulates Dopamine Drd3 Receptor Trafficking and Signaling. |
Q90210858 | A Genetically Encoded Fluorescent Sensor Enables Rapid and Specific Detection of Dopamine in Flies, Fish, and Mice |
Q41444993 | A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus |
Q37058350 | A Polymorphism within the Promoter of the Dopamine Receptor D1 (DRD1 -48A/G) Associates with Impaired Kidney Function in White Hypertensive Patients |
Q39164786 | A Role for Adenosine A1 Receptors in GABA and NMDA-Receptor Mediated Modulation of Dopamine Release: Studies Using Fast Cyclic Voltammetry |
Q30474975 | A behavioral genetics approach to understanding D1 receptor involvement in phasic dopamine signaling |
Q31002484 | A cell-based microarrayed compound screening format for identifying agonists of G-protein-coupled receptors |
Q34490940 | A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice |
Q33921257 | A functional fast scan cyclic voltammetry assay to characterize dopamine D2 and D3 autoreceptors in the mouse striatum |
Q97531550 | A low dosage of the dopamine D2-receptor antagonist sulpiride affects effort allocation for reward regardless of trait extraversion |
Q33770771 | A new approach for structure analysis of two-dimensional membrane protein crystals using X-ray powder diffraction data. |
Q28206321 | A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase |
Q36036244 | A novel insulinotropic mechanism of whole grain-derived γ-oryzanol via the suppression of local dopamine D2 receptor signalling in mouse islet |
Q35682160 | A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features |
Q38660754 | A novel role for dopamine signaling in the pathogenesis of bone loss from the atypical antipsychotic drug risperidone in female mice |
Q34356107 | A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism |
Q28118906 | A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health |
Q38168871 | A synergistic approach towards understanding the functional significance of dopamine receptor interactions |
Q35153384 | A tale of two rhythms: the emerging roles of oxytocin in rhythmic prolactin release. |
Q30429218 | A1 receptors self-regulate adenosine release in the striatum: evidence of autoreceptor characteristics. |
Q47806397 | ALDH2 modulated changes in cytokine levels and cognitive function in bipolar disorder: A 12-week follow-up study |
Q36681759 | ARF6 and GASP-1 are post-endocytic sorting proteins selectively involved in the intracellular trafficking of dopamine D₂ receptors mediated by GRK and PKC in transfected cells |
Q41456216 | Abnormalities of Dopamine D3 Receptor Signaling in the Diseased Brain |
Q46863837 | Absence of amino acid-induced glomerular hyperfiltration in dopamine D3 receptor knockout mice |
Q44640893 | Absence of circadian clock regulation of horizontal cell gap junctional coupling reveals two dopamine systems in the goldfish retina |
Q60956174 | Accurate Estimation of Ligand Binding Affinity Changes upon Protein Mutation |
Q35975080 | Acetylcholine α7 nicotinic and dopamine D2 receptors are targeted to many of the same postsynaptic dendrites and astrocytes in the rodent prefrontal cortex. |
Q34536809 | Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers |
Q38261700 | Activation of D2-like dopamine receptors inhibits GABA and glycinergic neurotransmission to pre-motor cardiac vagal neurons in the nucleus ambiguus |
Q42954376 | Activation of D2-like dopamine receptors inhibits young hormone degradation in female Drosophila. |
Q46350232 | Activation of DRD5 (dopamine receptor D5) inhibits tumor growth by autophagic cell death |
Q38270803 | Activation of Dopamine D1 Receptors Regulates Dendritic Morphogenesis Through Rac1 and RhoA in Prefrontal Cortex Neurons |
Q41022357 | Activation of Dopamine D1 Receptors in Dermal Fibroblasts Restores Vascular Endothelial Growth Factor-A Production by These Cells and Subsequent Angiogenesis in Diabetic Cutaneous Wound Tissues |
Q30458968 | Activation of GABA(B) receptors inhibits protein kinase B/glycogen synthase kinase 3 signaling |
Q24564691 | Activation of dopamine D4 receptors by ABT-724 induces penile erection in rats |
Q40972315 | Activation of human D3 dopamine receptor inhibits P/Q-type calcium channels and secretory activity in AtT-20 cells. |
Q33804521 | Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions |
Q42371781 | Activation-Induced Conformational Changes of Dopamine D3 Receptor Promote the Formation of the Internal Water Channel |
Q35046905 | Active and total transforming growth factor-β1 are differentially regulated by dopamine and estradiol in the pituitary |
Q36808288 | Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish |
Q36973390 | Adenosine A(2A) receptors in Parkinson's disease treatment |
Q36083482 | Adenosine and brain function |
Q48093155 | Adenosine modulates light responses of rat retinal ganglion cell photoreceptors througha cAMP-mediated pathway |
Q35766214 | Adolescent brain maturation is necessary for adult-typical mesocorticolimbic responses to a rewarding social cue. |
Q28570485 | Adolescent changes in dopamine D1 receptor expression in orbitofrontal cortex and piriform cortex accompany an associative learning deficit |
Q38656262 | Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds |
Q27690905 | Advances in cortical modulation of pain |
Q33744466 | Advances in genetic studies of substance abuse in China |
Q38123275 | Advances in the pharmacological treatment of Parkinson's disease: targeting neurotransmitter systems |
Q38092089 | Advancing addiction treatment: what can we learn from animal studies? |
Q40851683 | Advantages of heterologous expression of human D2long dopamine receptors in human neuroblastoma SH-SY5Y over human embryonic kidney 293 cells |
Q33735970 | Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D(2) receptors |
Q37440525 | Airway smooth muscle in airway reactivity and remodeling: what have we learned? |
Q34989845 | Alcohol abuse and HIV infection: role of DRD2 |
Q34206423 | Alteration of striatal dopaminergic neurotransmission in a mouse model of DYT11 myoclonus-dystonia |
Q34441585 | Altered adrenergic receptor signaling following traumatic brain injury contributes to working memory dysfunction |
Q36937690 | Altered dendritic distribution of dopamine D2 receptors and reduction in mitochondrial number in parvalbumin-containing interneurons in the medial prefrontal cortex of cannabinoid-1 (CB1) receptor knockout mice |
Q46913617 | Aluminum exposure decreases dopamine D1 and D2 receptor expression in mouse brain |
Q36778310 | Aminergic control and modulation of honeybee behaviour |
Q35126417 | Amphetamine alters behavior and mesocorticolimbic dopamine receptor expression in the monogamous female prairie vole. |
Q33757569 | Amphioxus expresses both vertebrate-type and invertebrate-type dopamine D(1) receptors |
Q24310712 | An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior |
Q36730191 | An assessment of molecular pathways of obesity susceptible to nutrient, toxicant and genetically induced epigenetic perturbation |
Q24683864 | Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SAR |
Q64241187 | Analysis of Structure and Dynamics in Three-Neuron Motifs |
Q42048080 | Analysis of two D1-like dopamine receptors from the honey bee Apis mellifera reveals agonist-independent activity. |
Q42484453 | Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons |
Q28506753 | Anatomical transcriptome of G protein-coupled receptors leads to the identification of a novel therapeutic candidate GPR52 for psychiatric disorders |
Q34065808 | Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats |
Q26765884 | Animal Models of Maladaptive Traits: Disorders in Sensorimotor Gating and Attentional Quantifiable Responses as Possible Endophenotypes. |
Q47129910 | Anti-cancer effects of dopamine in human glioma: involvement of mitochondrial apoptotic and anti-inflammatory pathways |
Q35441776 | Anti-incretin, Anti-proliferative Action of Dopamine on β-Cells |
Q40639740 | Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumor cells. |
Q73964407 | Antidyskinetic effect of JL-18, a clozapine analog, in parkinsonian monkeys |
Q27315976 | Antinociceptive activity of the ethanolic extract, fractions, and aggregatin D isolated from Sinningia aggregata tubers |
Q48250330 | Antinociceptive activity of the new triple reuptake inhibitor NS18283 in a mouse model of chemotherapy-induced neuropathic pain |
Q37079678 | Antiparkinson prodrugs |
Q61449987 | Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects |
Q30455338 | Antipsychotic drug effects in schizophrenia: a review of longitudinal FMRI investigations and neural interpretations |
Q36852489 | Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis |
Q34055216 | Apo-Ghrelin Receptor (apo-GHSR1a) Regulates Dopamine Signaling in the Brain |
Q35719941 | Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism |
Q42873823 | Aripiprazole an atypical antipsychotic protects against ethanol induced gastric ulcers in rats. |
Q39749438 | Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. |
Q27309159 | Aromatic L-amino acid decarboxylase (AADC) is crucial for brain development and motor functions |
Q36779793 | Arrestin-dependent but G-protein coupled receptor kinase-independent uncoupling of D2-dopamine receptors |
Q40203026 | Arthropod D2 receptors positively couple with cAMP through the Gi/o protein family |
Q38381081 | Assessment of dopamine D₁ receptor affinity and efficacy of three tetracyclic conformationally-restricted analogs of SKF38393 |
Q33811579 | Association of Dopamine D1 and D3 Receptor Gene Polymorphisms with Essential Hypertension in 3 Ethnic Groups in China |
Q33860047 | Association of a missense change in the D2 dopamine receptor with myoclonus dystonia |
Q43930636 | Association of dopamine D(3) receptors with actin-binding protein 280 (ABP-280). |
Q34139483 | Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14. |
Q37578164 | Attenuated dopaminergic tone in the paraventricular nucleus contributing to sympathoexcitation in rats with Type 2 diabetes |
Q43694305 | Atypical protein kinase C is a novel mediator of dopamine-enhanced firing in nucleus accumbens neurons. |
Q40700867 | Autocrine activation of adenosine A1 receptors blocks D1A but not D1B dopamine receptor desensitization |
Q37124518 | Autonomic nervous system and risk factors for vascular disease. Effects of autonomic unbalance in schizophrenia and Parkinson's disease |
Q49146144 | Autoradiographic analysis of dopamine receptor-stimulated [(35)S]GTPgammaS binding in rat striatum. |
Q33571819 | Autosomal-dominant striatal degeneration is caused by a mutation in the phosphodiesterase 8B gene |
Q37633385 | BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas |
Q24652896 | BTB Protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligase |
Q40901858 | Basal signaling activity of human dopamine D2L receptor demonstrated with an ecdysone-inducible mammalian expression system |
Q35842101 | Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease |
Q30492329 | Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective |
Q38677925 | Best candidates for dopamine agonist withdrawal in patients with prolactinomas. |
Q39851419 | Beta-adrenoceptor-mediated vasodilation of retinal blood vessels is reduced in streptozotocin-induced diabetic rats |
Q35505900 | Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors |
Q48411370 | Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons. |
Q28565562 | Binding of losartan to angiotensin AT1 receptors increases dopamine D1 receptor activation |
Q33847160 | Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457. |
Q36938316 | Biological treatments for amfetamine dependence : recent progress |
Q28392275 | Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder |
Q37484064 | Both neurons and astrocytes exhibited tetrodotoxin-resistant metabotropic glutamate receptor-dependent spontaneous slow Ca2+ oscillations in striatum |
Q28392759 | Brain deposition and neurotoxicity of manganese in adult mice exposed via the drinking water |
Q38254738 | Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings |
Q48170494 | Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans |
Q35669949 | C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice |
Q24321812 | CIN85 regulates dopamine receptor endocytosis and governs behaviour in mice |
Q34302065 | CREB modulates calcium signaling in cAMP-induced bone marrow stromal cells (BMSCs). |
Q22242364 | CRITICAL CARE ISSUES FOR THE NEPHROLOGIST: Low-dose Dopamine in the Intensive Care Unit |
Q39057164 | Cabergoline in acromegaly. |
Q44310853 | Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion |
Q24656080 | Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth |
Q38024032 | Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins. |
Q44403878 | Calcium-dependent, D2 receptor-independent induction of c-fos by haloperidol in dopamine neurons. |
Q36757540 | Canadian Association of Neurosciences Review: the role of dopamine receptor function in neurodegenerative diseases. |
Q99589427 | Candidate variants in TUB are associated with familial tremor |
Q46524353 | Carvacrol: from ancient flavoring to neuromodulatory agent. |
Q47275311 | Catecholamine reuptake inhibition causes weight loss by increasing locomotor activity and thermogenesis |
Q26743582 | Catecholamines and cognition after traumatic brain injury |
Q43755780 | Catecholamines in murine bone marrow derived mast cells |
Q28393537 | Cdk5 phosphorylates dopamine D2 receptor and attenuates downstream signaling |
Q36128635 | Cell Models for the Study of Sex Steroid Hormone Neurobiology. |
Q36983428 | Cell biology and pathophysiology of the diacylglycerol kinase family: morphological aspects in tissues and organs |
Q35151927 | Cell signaling underlying epileptic behavior. |
Q37332784 | Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs |
Q90133279 | Cellular Mechanisms for Antinociception Produced by Oxytocin and Orexins in the Rat Spinal Lamina II-Comparison with Those of Other Endogenous Pain Modulators |
Q34251305 | Cellular and molecular specificity of pituitary gland physiology |
Q44129120 | Cellular effects of dopamine--beyond oxidative mechanisms. |
Q45083552 | Central dopamine receptors: general considerations (Part 1) |
Q45113516 | Central dopaminergic receptors (Part II): pathophysiological and therapeutic considerations |
Q36253550 | Central dopaminergic system and its implications in stress-mediated neurological disorders and gastric ulcers: short review. |
Q58852452 | Chapter I The organization and circuits of mesencephalic dopaminergic neurons and the distribution of dopamine receptors in the brain |
Q35050698 | Characterisation of AmphiAmR11, an amphioxus (Branchiostoma floridae) D2-dopamine-like G protein-coupled receptor |
Q36369800 | Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. |
Q45299671 | Characterization of Antibodies to Identify Cellular Expression of Dopamine Receptor 4. |
Q30379878 | Characterization of ST14A Cells for Studying Modulation of Voltage-Gated Calcium Channels. |
Q41993974 | Characterization of [(3) H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand |
Q39036634 | Characterization of an invertebrate-type dopamine receptor of the American cockroach, Periplaneta americana |
Q36075795 | Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET. |
Q39419249 | Characterizing ingestive behavior through licking microstructure: Underlying neurobiology and its use in the study of obesity in animal models |
Q33768527 | Chiral Resolution and Serendipitous Fluorination Reaction for the Selective Dopamine D3 Receptor Antagonist BAK2-66 |
Q48199517 | Cholinesterase and monoamine oxidase activity in relation to mercury levels in the cerebral cortex of wild river otters |
Q37027130 | Chronic Exposure to Arsenic in Drinking Water Causes Alterations in Locomotor Activity and Decreases Striatal mRNA for the D2 Dopamine Receptor in CD1 Male Mice |
Q44506333 | Chronic administration with nandrolone decanoate induces alterations in the gene-transcript content of dopamine D(1)- and D(2)-receptors in the rat brain |
Q35287737 | Chronic intermittent ethanol exposure reduces presynaptic dopamine neurotransmission in the mouse nucleus accumbens. |
Q34192196 | Chronic intermittent hypoxia affects integration of sensory input by neurons in the nucleus tractus solitarii |
Q57023515 | Chronic social isolation stress during peri-adolescence alters presynaptic dopamine terminal dynamics via augmentation in accumbal dopamine availability |
Q34290554 | Circadian clock regulation of neuronal light responses in the vertebrate retina |
Q28480542 | Circadian-related heteromerization of adrenergic and dopamine D₄ receptors modulates melatonin synthesis and release in the pineal gland |
Q43680262 | Circulating dopamine level, in lung carcinoma patients, inhibits proliferation and cytotoxicity of CD4+ and CD8+ T cells by D1 dopamine receptors: an in vitro analysis |
Q39250251 | Clarifying the Ghrelin System's Ability to Regulate Feeding Behaviours Despite Enigmatic Spatial Separation of the GHSR and Its Endogenous Ligand |
Q36022700 | Clinical aspects and management of levodopa-induced dyskinesia. |
Q33927928 | Cocaine enhancement of long-term potentiation in the CA1 region of rat hippocampus: lamina-specific mechanisms of action |
Q38180393 | Cocaine-induced changes in NMDA receptor signaling |
Q38342952 | Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. |
Q35137741 | Cocaine-seeking is associated with PKC-dependent reduction of excitatory signaling in accumbens shell D2 dopamine receptor-expressing neurons |
Q48609200 | Cognitive Effects of Nicotine: Recent Progress. |
Q30474904 | Cognitive effects of nicotine: genetic moderators |
Q25255003 | Color naming deficits and attention-deficit/hyperactivity disorder: a retinal dopaminergic hypothesis |
Q38618494 | Comparison of Spreading Depolarizations in the Motor Cortex and Nucleus Accumbens: Similar Patterns of Oxygen Responses and the Role of Dopamine |
Q30495714 | Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors |
Q47658773 | Computer-aided drug design applied to Parkinson targets |
Q33884724 | Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors |
Q91717203 | Conformational pathway provides unique sensitivity to a synaptic mGluR |
Q38931189 | Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation |
Q34345506 | Constructing endophenotypes of complex diseases using non-negative matrix factorization and adjusted rand index |
Q97419894 | Contemporary Management of Clinically Non-functioning Pituitary Adenomas: A Clinical Review |
Q36102932 | Contribution of dopamine receptors to periaqueductal gray-mediated antinociception. |
Q34394799 | Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs |
Q37919731 | Control of striatal signaling by g protein regulators |
Q38177261 | Convergence of dopamine and glutamate signaling onto striatal ERK activation in response to drugs of abuse. |
Q46586671 | Cooperative activation of D1 and D2 dopamine receptors enhances a hyperpolarization-activated inward current in layer I interneurons. |
Q44208702 | Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits. |
Q35537656 | Corticolimbic catecholamines in stress: a computational model of the appraisal of controllability |
Q28138148 | Coupling of dopamine receptor subtypes to multiple and diverse G proteins |
Q44240890 | Critical periods of the dopaminergic system formation in rat brain. |
Q34400382 | Cross interaction of dopaminergic and adrenergic systems in neural modulation |
Q47669070 | Cross-Generational trans Fat Consumption Favors Self-Administration of Amphetamine and Changes Molecular Expressions of BDNF, DAT, and D1/D2 Receptors in the Cortex and Hippocampus of Rats |
Q33934123 | Curcumin modulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of streptozotocin induced diabetic rats |
Q39147170 | Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors |
Q39063051 | Cyclic ADP-ribose as an endogenous inhibitor of the mTOR pathway downstream of dopamine receptors in the mouse striatum |
Q87945516 | Cyclic AMP-producing chemogenetic activation of indirect pathway striatal projection neurons and the downstream effects on the globus pallidus and subthalamic nucleus in freely moving mice |
Q44923308 | D(1)-like receptors in the nucleus accumbens shell regulate the expression of contextual fear conditioning and activity of the anterior cingulate cortex in rats |
Q35618940 | D(2)-Dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions |
Q48173248 | D1 Antagonists and D2 Agonists Have Opposite Effects on the Metabolism of Dopamine in the Rat Striatum. |
Q34094439 | D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells |
Q35126684 | D1 and NMDA receptors hook up: expanding on an emerging theme |
Q37309537 | D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice |
Q28483848 | D1 dopamine receptor signaling is modulated by the R7 RGS protein EAT-16 and the R7 binding protein RSBP-1 in Caenoerhabditis elegans motor neurons |
Q48691424 | D1- and D2-like dopamine receptors within the nucleus accumbens contribute to stress-induced analgesia in formalin-related pain behaviours in rats. |
Q30451613 | D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms |
Q34315037 | D1-like dopamine receptor activation modulates GABAergic inhibition but not electrical coupling between neocortical fast-spiking interneurons |
Q43018188 | D2 Dopamine receptor subtype mediates the inhibitory effect of dopamine on TRH-induced prolactin release from the bullfrog pituitary |
Q28581786 | D2 dopamine receptor expression and trafficking is regulated through direct interactions with ZIP |
Q98237639 | D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density |
Q34397299 | D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. |
Q43875524 | D2 receptors inhibit the secretory process downstream from calcium influx in dopaminergic neurons: implication of K+ channels |
Q92132496 | D2-Like Receptors Mediate Dopamine-Inhibited Insulin Secretion via Ion Channels in Rat Pancreatic β-Cells |
Q34376205 | D3 dopamine receptor, behavioral sensitization, and psychosis |
Q46445025 | D4 dopamine receptor high-resolution structures enable the discovery of selective agonists. |
Q42436820 | D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. |
Q55291581 | D5 dopamine receptors control glutamatergic AMPA transmission between the motor cortex and subthalamic nucleus. |
Q37483792 | DNA targeting of rhinal cortex D2 receptor protein reversibly blocks learning of cues that predict reward. |
Q64777182 | DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum |
Q53610626 | DRD2/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma. |
Q34002281 | Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity |
Q34866730 | Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice. |
Q30453635 | Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action |
Q86825974 | Delineation of domains within the cannabinoid CB1 and dopamine D2 receptors that mediate the formation of the heterodimer complex |
Q36906393 | Dependence of spontaneous electrical activity and basal prolactin release on nonselective cation channels in pituitary lactotrophs. |
Q34659433 | Descending control of pain |
Q35817048 | Desensitization of G protein-coupled receptors and neuronal functions |
Q33854287 | Desensitized D2 autoreceptors are resistant to trafficking |
Q42475223 | Development of a dopaminergic system in sea urchin embryos and larvae |
Q58567796 | Development of a peptide targeting dopamine transporter to improve ADHD-like deficits |
Q90672376 | Developmental Exposure to Atrazine Impairs Spatial Memory and Downregulates the Hippocampal D1 Dopamine Receptor and cAMP-Dependent Signaling Pathway in Rats |
Q27024247 | Developmental origins of brain disorders: roles for dopamine |
Q27321884 | Developmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystonia |
Q42808349 | Diacylglycerol and ceramide formation induced by dopamine D2S receptors via Gbeta gamma -subunits in Balb/c-3T3 cells |
Q33257720 | Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis |
Q58764775 | Differential Dopamine D1 and D3 Receptor Modulation and Expression in the Spinal Cord of Two Mouse Models of Restless Legs Syndrome |
Q30412496 | Differential Effect of the Dopamine D3 Agonist (±)-7-Hydroxy-2-(N,N-di-n-propylamino) Tetralin (7-OH-DPAT) on Motor Activity between Adult Wistar and Sprague-Dawley Rats after a Neonatal Ventral Hippocampus Lesion |
Q41199596 | Differential Patterns of Alcohol Consumption and Dopamine-2 Receptor Binding in Wistar-Kyoto and Wistar Rats |
Q30436442 | Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. |
Q91198538 | Differential allosteric modulation within dopamine D2R - neurotensin NTS1R and D2R - serotonin 5-HT2AR receptor complexes gives bias to intracellular calcium signalling |
Q44385248 | Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum |
Q24291554 | Differential dependence of the D1 and D5 dopamine receptors on the G protein gamma 7 subunit for activation of adenylylcyclase |
Q39906615 | Differential effects of AGS3 expression on D(2L) dopamine receptor-mediated adenylyl cyclase signaling |
Q34881236 | Differential effects of a selective dopamine D1-like receptor agonist on motor activity and c-fos expression in the frontal-striatal circuitry of SHR and Wistar-Kyoto rats |
Q24338948 | Differential effects of the HESR/HEY transcription factor family on dopamine transporter reporter gene expression via variable number of tandem repeats |
Q35622636 | Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin |
Q24564345 | Differential roles of the dopamine 1-class receptors, D1R and D5R, in hippocampal dependent memory |
Q30920372 | Differential subcellular localization of two dopamine D2 receptor isoforms in transfected NG108‐15 cells |
Q40737449 | Differentiation of forebrain and hippocampal dopamine 1-class receptors, D1R and D5R, in spatial learning and memory |
Q45064807 | Direct Midbrain Dopamine Input to the Suprachiasmatic Nucleus Accelerates Circadian Entrainment |
Q37342011 | Direct inhibition of basolateral Kir4.1/5.1 and Kir4.1 channels in the cortical collecting duct by dopamine |
Q46564508 | Direct inhibition of substantia gelatinosa neurones in the rat spinal cord by activation of dopamine D2-like receptors. |
Q28144080 | Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors |
Q38301403 | Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia |
Q37680038 | Disease-specific heteromerization of G-protein-coupled receptors that target drugs of abuse |
Q33893744 | Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex |
Q33853927 | Dissociable contribution of prefrontal and striatal dopaminergic genes to learning in economic games. |
Q36653815 | Dissociable dopaminergic control of saccadic target selection and its implications for reward modulation |
Q64076594 | Distinct Dopamine D₂ Receptor Antagonists Differentially Impact D₂ Receptor Oligomerization |
Q95803381 | Distinct Effects of Chronic Dopaminergic Stimulation on Hippocampal Neurogenesis and Striatal Doublecortin Expression in Adult Mice |
Q37515058 | Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties. |
Q36288145 | Distinct dynamin-dependent and -independent mechanisms target structurally homologous dopamine receptors to different endocytic membranes |
Q40891262 | Distinct function of the cytoplasmic tail in human D1-like receptor ligand binding and coupling |
Q44714842 | Distinct in vitro interaction pattern of dopamine receptor subtypes with adaptor proteins involved in post-endocytotic receptor targeting |
Q33962164 | Distinct roles for Galpha(i)2 and Gbetagamma in signaling to DNA synthesis and Galpha(i)3 in cellular transformation by dopamine D2S receptor activation in BALB/c 3T3 cells |
Q36644971 | Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens |
Q44309218 | Distribution of dopamine D2 receptor mRNAs in the brain and the pituitary of female rainbow trout: an in situ hybridization study |
Q36241219 | Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype? |
Q33719306 | Does the difference between physically active and couch potato lie in the dopamine system? |
Q33894877 | Dopamine 2 Receptor Activation Entrains Circadian Clocks in Mouse Retinal Pigment Epithelium |
Q43267898 | Dopamine D(1) receptor activation of adenylyl cyclase, not phospholipase C, in the nucleus accumbens promotes maternal behavior onset in rats |
Q28366231 | Dopamine D(2)-like receptors selectively block N-type Ca(2+) channels to reduce GABA release onto rat striatal cholinergic interneurones |
Q44334327 | Dopamine D(4) receptor activation decreases the expression of mu-opioid receptors in the rat striatum |
Q52027740 | Dopamine D-5 receptor modulates hippocampal acetylcholine release. |
Q41832853 | Dopamine D1 and D2 antagonist effects on response likelihood and duration |
Q34020446 | Dopamine D1 and D3 receptors are differentially involved in cue-elicited cocaine seeking |
Q33869687 | Dopamine D1 receptor activation induces dehydroepiandrosterone sulfotransferase (SULT2A1) in HepG2 cells |
Q48223756 | Dopamine D1 receptor activation regulates sodium channel-dependent EPSP amplification in rat prefrontal cortex pyramidal neurons |
Q44533653 | Dopamine D1 receptor-dependent inhibition of NaCl transport in the rat thick ascending limb: mechanism of action |
Q38868116 | Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons |
Q37772934 | Dopamine D1 receptors, regulation of gene expression in the brain, and neurodegeneration |
Q21198880 | Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance |
Q34568648 | Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway |
Q36901098 | Dopamine D1-like and D2-like receptors in the dorsal striatum control different aspects of attentional performance in the five-choice serial reaction time task under a condition of increased activity of corticostriatal inputs |
Q33709567 | Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression |
Q39307372 | Dopamine D1/D5, But not D2/D3, Receptor Dependency of Synaptic Plasticity at Hippocampal Mossy Fiber Synapses that Is Enabled by Patterned Afferent Stimulation, or Spatial Learning. |
Q90673950 | Dopamine D2 Receptor-Mediated Modulation of Rat Retinal Ganglion Cell Excitability |
Q46632836 | Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation |
Q50523261 | Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae. |
Q41899842 | Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. |
Q54940084 | Dopamine D2 receptor gene polymorphisms and externalizing behaviors in children and adolescents. |
Q84602992 | Dopamine D2 receptor gene −141C Insertion/Deletion polymorphism in Turkish schizophrenic patients |
Q43668133 | Dopamine D2 receptor mediated presynaptic inhibition of striatopallidal GABA(A) IPSCs in vitro |
Q33519066 | Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation |
Q36254196 | Dopamine D2 receptor-mediated Akt/PKB signalling: initiation by the D2S receptor and role in quinpirole-induced behavioural activation |
Q43804886 | Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra |
Q43856112 | Dopamine D2 receptors are present in prefrontal cortical afferents and their targets in patches of the rat caudate-putamen nucleus |
Q50994126 | Dopamine D2 receptors dimers: how can we pharmacologically target them? |
Q34372135 | Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling |
Q33552861 | Dopamine D2-receptor activation elicits akinesia, rigidity, catalepsy, and tremor in mice expressing hypersensitive {alpha}4 nicotinic receptors via a cholinergic-dependent mechanism |
Q37576818 | Dopamine D2R Agonist-Induced Cardiovascular Effects in Healthy Male Subjects: Potential Implications in Clinical Settings. |
Q28067056 | Dopamine D3 Receptor Antagonists as Potential Therapeutics for the Treatment of Neurological Diseases |
Q41954081 | Dopamine D3 Receptors Inhibit Hippocampal Gamma Oscillations by Disturbing CA3 Pyramidal Cell Firing Synchrony. |
Q43965668 | Dopamine D3 receptor activation promotes neural stem/progenitor cell proliferation through AKT and ERK1/2 pathways and expands type-B and -C cells in adult subventricular zone |
Q34386011 | Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs |
Q40555581 | Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord |
Q39772838 | Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathways |
Q43744053 | Dopamine D3 receptors are involved in amphetamine-induced contralateral rotation in 6-OHDA lesioned rats |
Q43727927 | Dopamine D4 receptor activation inhibits presynaptically glutamatergic neurotransmission in the rat supraoptic nucleus |
Q28582297 | Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release |
Q28586485 | Dopamine D5 receptor modulates male and female sexual behavior in mice |
Q33751420 | Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area |
Q33809050 | Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO. |
Q54983742 | Dopamine Promotes Ascorbate Release from Retinal Neurons: Role of D1 Receptors and the Exchange Protein Directly Activated by cAMP type 2 (EPAC2). |
Q92510309 | Dopamine Receptor Blockade Attenuates Purinergic P2X4 Receptor-Mediated Prepulse Inhibition Deficits and Underlying Molecular Mechanisms |
Q54978593 | Dopamine Receptor Subtypes Differentially Regulate Autophagy. |
Q26783348 | Dopamine Receptors and Neurodegeneration |
Q47639733 | Dopamine Regulation of Amygdala Inhibitory Circuits for Expression of Learned Fear |
Q49344579 | Dopamine Secretion Is Mediated by Sparse Active Zone-like Release Sites. |
Q64914498 | Dopamine Signaling in Circadian Photoentrainment: Consequences of Desynchrony. |
Q36512027 | Dopamine activates noradrenergic receptors in the preoptic area. |
Q47715905 | Dopamine agonists can improve pure apathy associated with lesions of the prefrontal-basal ganglia functional system |
Q90654820 | Dopamine and addiction: what have we learned from 40 years of research |
Q46815699 | Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration |
Q35796578 | Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor |
Q36986112 | Dopamine and migraine: biology and clinical implications |
Q46886555 | Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat. |
Q28589624 | Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors |
Q28754880 | Dopamine binds to alpha(2)-adrenergic receptors in the song control system of zebra finches (Taeniopygia guttata) |
Q35023940 | Dopamine blocks stress-mediated ovarian carcinoma growth |
Q48031586 | Dopamine cross-reacts with adrenoreceptors in cortical astrocytes to induce BDNF expression, CREB signaling and morphological transformation. |
Q44658136 | Dopamine depresses cholinergic oscillatory network activity in rat hippocampus |
Q43206399 | Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II. |
Q45394925 | Dopamine directly modulates GABAA receptors |
Q52745654 | Dopamine effect on 20-hydroxyecdysone level is mediated by juvenile hormone in Drosophila females. |
Q34762829 | Dopamine effects on identified rat vagal motoneurons |
Q37075384 | Dopamine in plasma - a biomarker for myofascial TMD pain? |
Q73011751 | Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat |
Q27316037 | Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis |
Q39553968 | Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex |
Q42064602 | Dopamine induces Ca2+ signaling in astrocytes through reactive oxygen species generated by monoamine oxidase |
Q43814491 | Dopamine inhibition of evoked IPSCs in rat prefrontal cortex |
Q37190529 | Dopamine inhibits N-type channels in visceral afferents to reduce synaptic transmitter release under normoxic and chronic intermittent hypoxic conditions |
Q36513166 | Dopamine inhibits basal prolactin release in pituitary lactotrophs through pertussis toxin-sensitive and -insensitive signaling pathways |
Q27300818 | Dopamine inhibits mitochondrial motility in hippocampal neurons |
Q35227738 | Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity |
Q30482742 | Dopamine is necessary for cue-dependent fear conditioning |
Q43052939 | Dopamine level in the medulla oblongata is under the control of chromosome 8 locus in ISIAH rats |
Q44201735 | Dopamine mediates circadian clock regulation of rod and cone input to fish retinal horizontal cells |
Q30011102 | Dopamine modulates excitability of spiny neurons in the avian basal ganglia. |
Q35856411 | Dopamine modulates hemocyte phagocytosis via a D1-like receptor in the rice stem borer, Chilo suppressalis |
Q33490598 | Dopamine modulates persistent synaptic activity and enhances the signal-to-noise ratio in the prefrontal cortex |
Q44211152 | Dopamine modulates synaptic transmission in the nucleus of the solitary tract |
Q30476321 | Dopamine modulates the plasticity of mechanosensory responses in Caenorhabditis elegans. |
Q30491317 | Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia? |
Q48258175 | Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex |
Q44746580 | Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. |
Q47893555 | Dopamine on D2-like receptors "reboosts" dopamine D1-like receptor-mediated behavioural activation in rats licking for a isotonic NaCl solution |
Q35688765 | Dopamine partial agonists: a new class of antipsychotic |
Q35165378 | Dopamine polymorphisms and depressive symptoms predict foods intake. Results from a nationally representative sample |
Q48566002 | Dopamine presynaptically depresses fast inhibitory synaptic transmission via D4 receptor-protein kinase A pathway in the rat dorsolateral septal nucleus. |
Q36011180 | Dopamine receptor 1 localizes to neuronal cilia in a dynamic process that requires the Bardet-Biedl syndrome proteins |
Q34883582 | Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. |
Q102210970 | Dopamine receptor D1- and D2-agonists do not spark brown adipose tissue thermogenesis in mice |
Q57476647 | Dopamine receptor D2, but not D1, mediates descending dopaminergic pathway-produced analgesic effect in a trigeminal neuropathic pain mouse model |
Q35151769 | Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings |
Q28543414 | Dopamine receptor activation increases HIV entry into primary human macrophages |
Q33983589 | Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration |
Q44205689 | Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study |
Q34438043 | Dopamine receptor functions: lessons from knockout mice [corrected]. |
Q37903350 | Dopamine receptor interacting proteins: targeting neuronal calcium sensor-1/D2 dopamine receptor interaction for antipsychotic drug development |
Q35216451 | Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling. |
Q28256783 | Dopamine receptors - IUPHAR Review 13 |
Q37685694 | Dopamine receptors and L-dopa-induced dyskinesia |
Q35545020 | Dopamine receptors and Parkinson's disease |
Q37215549 | Dopamine receptors and hypertension |
Q35167141 | Dopamine receptors for every species: gene duplications and functional diversification in Craniates |
Q34038390 | Dopamine receptors in human adipocytes: expression and functions |
Q31120490 | Dopamine receptors modulate cytotoxicity of natural killer cells via cAMP-PKA-CREB signaling pathway |
Q34070870 | Dopamine receptors: from structure to behavior |
Q46095844 | Dopamine reduction of GABA currents in striatal medium-sized spiny neurons is mediated principally by the D(1) receptor subtype |
Q36494552 | Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization |
Q37421729 | Dopamine regulates renal osmoregulation during hyposaline stress via DRD1 in the spotted scat (Scatophagus argus). |
Q40352016 | Dopamine regulation of amiloride-sensitive sodium channels in lung cells. |
Q37312517 | Dopamine regulation of social choice in a monogamous rodent species |
Q90683211 | Dopamine response gene pathways in dorsal striatum MSNs from a gene expression viewpoint: cAMP-mediated gene networks |
Q30354575 | Dopamine signaling architecture in Caenorhabditis elegans. |
Q33784944 | Dopamine signaling in C. elegans is mediated in part by HLH-17-dependent regulation of extracellular dopamine levels |
Q21129462 | Dopamine signaling in reward-related behaviors |
Q46442166 | Dopamine signaling through D1-like versus D2-like receptors in the nucleus accumbens core versus shell differentially modulates nicotine reward sensitivity |
Q28477487 | Dopamine signalling in mushroom bodies regulates temperature-preference behaviour in Drosophila |
Q35650874 | Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells |
Q43845622 | Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism |
Q37592096 | Dopamine systems in the forebrain |
Q42489658 | Dopamine triggers skeletal muscle tone by activating D1-like receptors on somatic motoneurons |
Q31156614 | Dopamine type 2 receptor expression and function in rodent sensory neurons projecting to the airways |
Q33818213 | Dopamine, a neurotransmitter, influences the immune system |
Q34126224 | Dopamine, affordance and active inference |
Q36973467 | Dopamine, cognitive function, and gamma oscillations: role of D4 receptors. |
Q28580699 | Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes |
Q34126424 | Dopamine, hypertension and obesity |
Q33765532 | Dopamine-2 receptor activation suppresses PACAP expression in gonadotrophs |
Q42322627 | Dopamine-Induced Changes in Gαolf Protein Levels in Striatonigral and Striatopallidal Medium Spiny Neurons Underlie the Genesis of l-DOPA-Induced Dyskinesia in Parkinsonian Mice |
Q41969613 | Dopamine-dependent tuning of striatal inhibitory synaptogenesis. |
Q24815335 | Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease |
Q33862807 | Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor |
Q40842459 | Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells |
Q60141581 | Dopamine: Functions, Signaling, and Association with Neurological Diseases |
Q33761371 | Dopamine: a parallel pathway for the modulation of spinal locomotor networks. |
Q45081704 | Dopamine: should I stay or should I go now? |
Q46419877 | Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil |
Q39348712 | Dopaminergic Regulation of Innate Immunity: a Review. |
Q48435056 | Dopaminergic control of long-term depression/long-term potentiation threshold in prefrontal cortex. |
Q44262068 | Dopaminergic effects after chronic treatment with nandrolone visualized in rat brain by positron emission tomography |
Q36266555 | Dopaminergic effects on in vitro osteogenesis |
Q91920808 | Dopaminergic gene methylation is associated with cognitive performance in a childhood monozygotic twin study |
Q34774570 | Dopaminergic modulation of cortical inputs during maturation of adult-born dentate granule cells |
Q40155375 | Dopaminergic modulation of locomotor network activity in the neonatal mouse spinal cord. |
Q42481792 | Dopaminergic modulation of neurosecretory cells in the crayfish |
Q35828346 | Dopaminergic modulation of short-term synaptic plasticity at striatal inhibitory synapses |
Q30416302 | Dopaminergic modulation of the voltage-gated sodium current in the cochlear afferent neurons of the rat. |
Q35144772 | Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter |
Q48097672 | Dopaminergic regulation of three somatostatin mRNAs in goldfish brain |
Q37798319 | Dopaminergic reward system: a short integrative review |
Q35839434 | Dopaminergic signaling and striatal neurodegeneration in Huntington's disease |
Q36744457 | Dopaminergic signaling in dendritic spines |
Q28201520 | Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice |
Q28748894 | Dopaminergic system in birdsong learning and maintenance |
Q28655767 | Dopaminergic therapy in aphasia |
Q35669953 | Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine |
Q35000860 | Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. |
Q37446637 | Drugs, biogenic amine targets and the developing brain |
Q44803785 | Dual mode of catecholamine action on splenic macrophage phagocytosis in wall lizard, Hemidactylus flaviviridis |
Q28577705 | Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor |
Q39041217 | Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation |
Q33898069 | Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder |
Q28550695 | Effect of C-Terminal S-Palmitoylation on D2 Dopamine Receptor Trafficking and Stability |
Q47969108 | Effect of D-amphetamine on emotion-potentiated startle in healthy humans: implications for psychopathy and antisocial behaviour |
Q36776500 | Effect of Motor Impairment on Analgesic Efficacy of Dopamine D2/3 Receptors in a Rat Model of Neuropathy |
Q34278294 | Effect of atomoxetine on hyperactivity in an animal model of attention-deficit/hyperactivity disorder (ADHD). |
Q33739069 | Effect of betamethasone on the expression of dopamine D1 receptor mRNA in the developing rabbit adrenal gland |
Q36124382 | Effect of clozapine on locomotor activity and anxiety-related behavior in the neonatal mice administered MK-801. |
Q42035376 | Effect of cyclosporin A on the uptake of D3-selective PET radiotracers in rat brain |
Q48142886 | Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). |
Q33729782 | Effect of high-fat feeding on expression of genes controlling availability of dopamine in mouse hypothalamus |
Q35881733 | Effects of Dopamine D2-Like Receptor Antagonists on Light Responses of Ganglion Cells in Wild-Type and P23H Rat Retinas |
Q37337627 | Effects of SKF-83566 and haloperidol on performance on progressive ratio schedules maintained by sucrose and corn oil reinforcement: quantitative analysis using a new model derived from the Mathematical Principles of Reinforcement (MPR). |
Q80975659 | Effects of activation and blockade of dopamine D(2) receptors on the immune response in mice with different types of behavior |
Q26785394 | Effects of anabolic-androgens on brain reward function |
Q30864878 | Effects of dopamine on human retinal vessel diameter and its modulation during flicker stimulation |
Q44965129 | Effects of dopamine on ion transport across the rat distal colon |
Q30830550 | Effects of dopamine on retinal and choroidal blood flow parameters in humans |
Q44892806 | Effects of dopexamine, dobutamine or dopamine on prolactin and thyreotropin serum concentrations in high-risk surgical patients |
Q44077887 | Effects of intrathecal injection of diatrizoate on dopamine receptors |
Q44173422 | Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size. |
Q48596287 | Effects of maternal separation and methamphetamine exposure on protein expression in the nucleus accumbens shell and core. |
Q38600073 | Effects of pair bonding on parental behavior and dopamine activity in the nucleus accumbens in male prairie voles |
Q44384986 | Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor |
Q35848385 | Effects of protein kinase A inhibitor and activator on rewarding effects of SKF-82958 microinjected into nucleus accumbens shell of ad libitum fed and food-restricted rats |
Q38325582 | Effects of reciprocal chimeras between the C-terminal portion of third intracellular loops of the human dopamine D2 and D3 receptors |
Q28535151 | Effects of the dopamine D2 allosteric modulator, PAOPA, on the expression of GRK2, arrestin-3, ERK1/2, and on receptor internalization |
Q83201094 | Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinoma |
Q40915306 | Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells |
Q34764040 | Electron microscopic immunolabeling of transporters and receptors identifies transmitter-specific functional sites envisioned in Cajal's neuron |
Q33685314 | Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug? |
Q24297398 | Elevated Intracellular Calcium Triggers Recruitment of the Receptor Cross-talk Accessory Protein Calcyon to the Plasma Membrane |
Q46758782 | Elevated mercury exposure and neurochemical alterations in little brown bats (Myotis lucifugus) from a site with historical mercury contamination |
Q35698989 | Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor |
Q42587323 | Embryonic and mature astrocytes exert different effects on neuronal growth in rat ventral mesencephalic slice cultures |
Q38811516 | Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease. |
Q39164389 | Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma |
Q38110685 | Endocrine regulation of prolactin cell function and modulation of osmoreception in the Mozambique tilapia |
Q48404644 | Endocytosis following dopamine D2 receptor activation is critical for neuronal activity and dendritic spine formation via Rabex-5/PDGFRβ signaling in striatopallidal medium spiny neurons. |
Q28116057 | Endocytosis promotes rapid dopaminergic signaling |
Q42745808 | Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study |
Q36893235 | Endogenous dopamine suppresses initiation of swimming in prefeeding zebrafish larvae |
Q46170231 | Enhanced dopamine D1 and D2 receptor gene expression in the hippocampus of hypoglycaemic and diabetic rats |
Q35089417 | Enhanced dopamine-dependent hippocampal plasticity after single MK-801 application. |
Q37384715 | Enhanced latent inhibition in dopamine receptor-deficient mice is sex-specific for the D1 but not D2 receptor subtype: implications for antipsychotic drug action. |
Q42788396 | Enhancement of odor avoidance regulated by dopamine signaling in Caenorhabditis elegans |
Q39058741 | Epigenetic repression of the dopamine receptor D4 in pediatric tumors of the central nervous system |
Q28513861 | Essential conservation of D1 mutant phenotype at the level of individual topographies of behaviour in mice lacking both D1 and D3 dopamine receptors |
Q43119654 | Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice. |
Q35789368 | Estrogen regulation of the dopamine-activated GIRK channel in pituitary lactotrophs: implications for regulation of prolactin release during the estrous cycle |
Q33848395 | Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland |
Q42496866 | Ether-à-go-go 1 (Eag1) potassium channel expression in dopaminergic neurons of basal ganglia is modulated by 6-hydroxydopamine lesion. |
Q37070133 | Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands. |
Q36733481 | Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist |
Q46116537 | Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice |
Q28576208 | Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization |
Q44930076 | Evolution and expression of D2 and D3 dopamine receptor genes in zebrafish. |
Q36701982 | Evolution of dopamine receptor genes of the D1 class in vertebrates. |
Q36068208 | Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D2 and D3 Receptors |
Q42435952 | Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology |
Q36211455 | Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases |
Q28077983 | Expanding frontiers in weight-control research explored by young investigators |
Q42070529 | Exploring genetic influences underlying acute aerobic exercise effects on motor learning. |
Q42814848 | Exploring mechanisms underlying extinction of cue-elicited cocaine seeking |
Q57819110 | Exposure to Maternal Diabetes Mellitus Causes Renal Dopamine D Receptor Dysfunction and Hypertension in Adult Rat Offspring |
Q37314246 | Expression analysis of dopamine receptor subtypes in normal human pituitaries, nonfunctioning pituitary adenomas and somatotropinomas, and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acrome |
Q33302616 | Expression and distribution of all dopamine receptor subtypes (D(1)-D(5)) in the mouse lumbar spinal cord: a real-time polymerase chain reaction and non-autoradiographic in situ hybridization study |
Q41225554 | Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer |
Q33268100 | Expression of Cre recombinase in dopaminoceptive neurons |
Q73897941 | Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment |
Q28579277 | Expression of D4 dopamine receptors in striatonigral and striatopallidal neurons in the rat striatum |
Q44414445 | Expression of a D1 dopamine receptor dDA1/DmDOP1 in the central nervous system of Drosophila melanogaster. |
Q40095717 | Expression of a Novel D4 Dopamine Receptor in the Lamprey Brain. Evolutionary Considerations about Dopamine Receptors. |
Q54360050 | Expression of dopamine 2 receptor subtype mRNA in clinically nonfunctioning pituitary adenomas. |
Q40724042 | Expression of dopamine receptors and transporter in neuroendocrine gastrointestinal tumor cells |
Q44135024 | Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake |
Q39794403 | Expression status of Zic family member 2 as a prognostic marker for oral squamous cell carcinoma |
Q34330022 | Extrastriatal dopaminergic circuits of the Basal Ganglia |
Q34204681 | Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice |
Q92145654 | Flow-activated proximal tubule function underlies glomerulotubular balance |
Q46707110 | Fluoxetine induces lean phenotype in rat by increasing the brown/white adipose tissue ratio and UCP1 expression |
Q30424415 | Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaine |
Q36853625 | Frequency-dependent gating of synaptic transmission and plasticity by dopamine |
Q35692408 | Friendships Moderate an Association Between a Dopamine Gene Variant and Political Ideology |
Q21558392 | From genes to behavior: placing cognitive models in the context of biological pathways |
Q43635181 | Functional characterization of basolateral and luminal dopamine receptors in rabbit CCD. |
Q27305293 | Functional mapping of protein kinase A reveals its importance in adult Schistosoma mansoni motor activity |
Q82029286 | Functional neurochemistry of the basal ganglia |
Q34129968 | Further delineation of hydrophobic binding sites in dopamine D(2)/D(3) receptors for N-4 substituents on the piperazine ring of the hybrid template 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol. |
Q28542580 | G protein beta 5 is targeted to D2-dopamine receptor-containing biochemical compartments and blocks dopamine-dependent receptor internalization |
Q30435176 | G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor |
Q33553460 | G protein-coupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation |
Q37200868 | G protein-coupled receptor kinase-mediated phosphorylation regulates post-endocytic trafficking of the D2 dopamine receptor. |
Q35682949 | G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice. |
Q37680849 | G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives |
Q35630448 | G-protein coupled receptor oligomerization in neuroendocrine pathways |
Q37594994 | GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling. |
Q80260930 | GPCR targeted library design: novel dopamine D3 receptor ligands |
Q64118684 | GPR139 and Dopamine D2 Receptor Co-express in the Same Cells of the Brain and May Functionally Interact |
Q37781424 | GSK-3β activity and hyperdopamine-dependent behaviors |
Q95792291 | Gain in sensitivity and loss in temporal contrast of STDP by dopaminergic modulation at hippocampal synapses |
Q91635472 | Gamma Oryzanol Alleviates High-Fat Diet-Induced Anxiety-Like Behaviors Through Downregulation of Dopamine and Inflammation in the Amygdala of Mice |
Q28577825 | Gene regulation of melatonin and dopamine receptors during eye development |
Q37724204 | Genetic association between the dopamine D1-receptor gene and paranoid schizophrenia in a northern Han Chinese population |
Q37945125 | Genetic determinants of aggression and impulsivity in humans |
Q37157279 | Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. |
Q35116207 | Genome-Wide Analyses of Working-Memory Ability: A Review |
Q34093922 | Geometry and kinetics of dopaminergic transmission in the rat striatum and in mice lacking the dopamine transporter |
Q37973031 | Gestational restraint stress and the developing dopaminergic system: an overview. |
Q48128071 | Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications. |
Q26783258 | Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target(1,2,3) |
Q45262349 | Growth hormone-induced stimulation of swimming and feeding behaviour of rainbow trout is abolished by the D1 dopamine antagonist SCH23390. |
Q38812005 | HIV, Tat and dopamine transmission. |
Q30479796 | Habituation and sensitization of acoustic startle: opposite influences of dopamine D1 and D2-family receptors |
Q36561952 | Haloperidol Suppresses NF-kappaB to Inhibit Lipopolysaccharide-Induced Pro-Inflammatory Response in RAW 264 Cells |
Q44348997 | Halothane attenuated haloperidol and enhanced clozapine-induced dopamine release in the rat striatum. |
Q43851069 | Halothane decreases impulse-dependent but not cytoplasmic release of dopamine from rat striatal slices |
Q48576907 | Halothane increases non-vesicular [(3)H]dopamine release from brain cortical slices. |
Q44036651 | Handling, genetic and housing effects on the mouse stress system, dopamine function, and behavior |
Q36191624 | Heptaspanning membrane receptors and cytoskeletal/scaffolding proteins: focus on adenosine, dopamine, and metabotropic glutamate receptor function |
Q92642583 | Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D2 Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor |
Q89707422 | Heterogeneity in striatal dopamine circuits: Form and function in dynamic reward seeking |
Q37379456 | Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance |
Q24652245 | Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms |
Q57183263 | High Sensitivity Mapping of Cortical Dopamine D2 Receptor Expressing Neurons |
Q40586964 | High-resolution voxelation mapping of human and rodent brain gene expression. |
Q45899153 | Hippocampal neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice following passive avoidance conditioning. |
Q38629710 | Hippocampus Contributions to Food Intake Control: Mnemonic, Neuroanatomical, and Endocrine Mechanisms |
Q41814232 | Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. |
Q42574775 | Homeostatic mechanisms in dopamine synthesis and release: a mathematical model |
Q40713809 | Homologous regulation of the heptahelical D1A receptor responsiveness: specific cytoplasmic tail regions mediate dopamine-induced phosphorylation, desensitization and endocytosis |
Q31041119 | Honey bee dopamine and octopamine receptors linked to intracellular calcium signaling have a close phylogenetic and pharmacological relationship. |
Q90632907 | How Sure Can We Be about ML Methods-Based Evaluation of Compound Activity: Incorporation of Information about Prediction Uncertainty Using Deep Learning Techniques |
Q36756201 | How adenylate cyclase choreographs the pas de deux of the receptors heteromerization dance |
Q30457477 | How antipsychotics work-from receptors to reality |
Q37829639 | How have developments in molecular imaging techniques furthered schizophrenia research? |
Q34131364 | How might cannabinoids influence sexual behavior? |
Q35647648 | Human embryonic stem cell-derived neurons adopt and regulate the activity of an established neural network |
Q37316522 | Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse |
Q28566012 | Hydrogen peroxide causes uncoupling of dopamine D1-like receptors from G proteins via a mechanism involving protein kinase C and G-protein-coupled receptor kinase 2 |
Q30475347 | Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice |
Q35546211 | Hypothalamic neuropeptide Y (NPY) and the attenuation of hyperphagia in streptozotocin diabetic rats treated with dopamine D1/D2 agonists |
Q57478856 | Identification of Alkaloids from W. T. Wang as Dopamine D₁ Receptor Antagonists by Using CRE-Luciferase Reporter Gene Assay |
Q34028214 | Identification of RanBP 9/10 as interacting partners for protein kinase C (PKC) gamma/delta and the D1 dopamine receptor: regulation of PKC-mediated receptor phosphorylation |
Q34423308 | Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand |
Q33604674 | Identification of a circadian clock-controlled neural pathway in the rabbit retina |
Q43868787 | Identification of a dopamine receptor from Caenorhabditis elegans |
Q48965500 | Identification of a dopamine receptor-mediated opiate reward memory switch in the basolateral amygdala-nucleus accumbens circuit. |
Q42867430 | Identification of a specific assembly of the g protein golf as a critical and regulated module of dopamine and adenosine-activated cAMP pathways in the striatum |
Q24651562 | Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum |
Q84784890 | Identification of dopamine D2 receptors in gill of Crassostrea virginica |
Q30698219 | Identification of dopamine responsive mRNAs in glial cells by suppression subtractive hybridization |
Q40735622 | Identification of functional dopamine receptors in human teratocarcinoma NT2 cells |
Q35005483 | Identification of the mRNA expression status of the dopamine D2 receptor and dopamine transporter in peripheral blood lymphocytes of schizophrenia patients |
Q48496117 | Identification of two functionally distinct endosomal recycling pathways for dopamine D₂ receptor. |
Q34995403 | Imaging of brain dopamine pathways: implications for understanding obesity |
Q34197072 | Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion |
Q28314672 | Impact of nutrition on canine behaviour: current status and possible mechanisms |
Q28587153 | Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase |
Q28591925 | Impaired light masking in dopamine D2 receptor-null mice |
Q38730424 | In Search of Concomitant Alterations of Dopaminergic and Neurotensinergic Systems in Stress Conditions |
Q41930844 | In hamsters the D1 receptor antagonist SCH23390 depresses ventilation during hypoxia |
Q37173272 | In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias |
Q35866876 | In vivo mesolimbic D2/3 receptor binding predicts posttherapeutic clinical responses in restless legs syndrome: a positron emission tomography study |
Q44341794 | Increased dopamine D2 receptor binding and enhanced apomorphine-induced locomotor activity in mu-opioid receptor knockout mice |
Q48953071 | Increased hippocampal CREB phosphorylation in dopamine D3 receptor knockout mice following passive avoidance conditioning. |
Q45951419 | Indoloquinolizidine-peptide hybrids as multiple agonists for D1 and D2 dopamine receptors. |
Q33570107 | Inflammation compromises renal dopamine D1 receptor function in rats |
Q64906046 | Inflammatory Signaling in Hypertension: Regulation of Adrenal Catecholamine Biosynthesis. |
Q64764797 | Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson's Disease |
Q34762698 | Influence of cocaine history on the behavioral effects of Dopamine D(3) receptor-selective compounds in monkeys |
Q34001519 | Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice |
Q24273361 | Inhibition of West Nile Virus Multiplication in Cell Culture by Anti-Parkinsonian Drugs |
Q37298514 | Inhibition of natriuretic factors increases blood pressure in rats |
Q37112269 | Inhibition of the dopamine D1 receptor signaling by PSD-95. |
Q36159254 | Inhibitory effects of dopamine on spinal synaptic transmission via dopamine D1-like receptors in neonatal rats. |
Q57041331 | Inhibitory responses in Aplysia pleural sensory neurons act to block excitability, transmitter release, and PKC Apl II activation |
Q36813512 | Injection of CART (cocaine- and amphetamine-regulated transcript) peptide into the nucleus accumbens reduces cocaine self-administration in rats |
Q40120084 | Insulin causes renal dopamine D1 receptor desensitization via GRK2-mediated receptor phosphorylation involving phosphatidylinositol 3-kinase and protein kinase C. |
Q33774774 | Integrating Neural Circuits Controlling Female Sexual Behavior |
Q34348803 | Interaction of novel hybrid compounds with the D3 dopamine receptor: Site-directed mutagenesis and homology modeling studies |
Q40015106 | Interaction with dopamine D2 receptor enhances expression of transient receptor potential channel 1 at the cell surface |
Q28204278 | Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor |
Q24317566 | Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors |
Q34094605 | Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers |
Q28573869 | Interactions of GIPC with Dopamine D2, D3but not D4Receptors Define a Novel Mode of Regulation of G Protein-coupled Receptors |
Q33805796 | Interplay among catecholamine systems: dopamine binds to alpha2-adrenergic receptors in birds and mammals |
Q104505911 | Intra-accumbal dopaminergic system modulates the restraint stress-induced antinociceptive behaviors in persistent inflammatory pain |
Q37916772 | Intrinsic and integrative properties of substantia nigra pars reticulata neurons |
Q34289950 | Inverted-U shaped effects of D1 dopamine receptor stimulation in the medial preoptic nucleus on sexually motivated song in male European starlings. |
Q35666067 | Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonists |
Q37239341 | Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol: effect on affinity and selectivity for dopamine D3 receptor |
Q93078709 | Involvement of CB2 Receptors in the Neurobehavioral Effects of Catha Edulis (Vahl) Endl. (Khat) in Mice |
Q48329152 | Involvement of dopamine D1 and D2 receptors in the rat nucleus accumbens in immunostimulation. |
Q44318940 | Involvement of dopamine D1 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. |
Q51026112 | Involvement of dopamine D2 receptors activation in ischemic post-conditioning-induced cardioprotection through promoting PKC-ε particulate translocation in isolated rat hearts. |
Q30457731 | Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing |
Q36003349 | Ion channels and signaling in the pituitary gland |
Q44316405 | Is there a role for rare variants in DRD4 gene in the susceptibility for ADHD? Searching for an effect of allelic heterogeneity. |
Q63533528 | Isolation of dopamine D2 receptor (D2R) promoters in Mugil cephalus |
Q37747091 | Japanese Encephalitis Virus Exploits Dopamine D2 Receptor-phospholipase C to Target Dopaminergic Human Neuronal Cells |
Q35179014 | Knockdown of dopamine D₂ receptors in the nucleus accumbens core suppresses methamphetamine-induced behaviors and signal transduction in mice. |
Q30387714 | Knowledge About Sounds-Context-Specific Meaning Differently Activates Cortical Hemispheres, Auditory Cortical Fields, and Layers in House Mice |
Q36087200 | L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease |
Q46506870 | L-dopa modulates motor cortex excitability in Alzheimer's disease patients |
Q35027709 | LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization |
Q34426902 | Lack or inhibition of dopaminergic stimulation induces a development increase of striatal tyrosine hydroxylase-positive interneurons |
Q55103495 | Left Parietal Functional Connectivity Mediates the Association Between COMT rs4633 and Verbal Intelligence in Healthy Adults. |
Q37133420 | Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism |
Q36599083 | Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome |
Q35913125 | Ligand-specific roles for transmembrane 5 serine residues in the binding and efficacy of dopamine D(1) receptor catechol agonists |
Q44625523 | Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder |
Q37416273 | Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade |
Q33781476 | Localization and function of dopamine receptors in the subthalamic nucleus of normal and parkinsonian monkeys. |
Q73145905 | Localization of dopamine receptors in the tree shrew brain using [3H]-SCH23390 and [125I]-epidepride |
Q40221989 | Locomotor activity is regulated by D2-like receptors in Drosophila: an anatomic and functional analysis |
Q43651479 | Locomotor behavior of dopamine D1 receptor transgenic/D2 receptor deficient hybrid mice |
Q47152336 | Locus Coeruleus and Dopamine-Dependent Memory Consolidation. |
Q44343162 | Long-term effects of maternal separation on ethanol intake and brain opioid and dopamine receptors in male wistar rats |
Q44604524 | Longitudinal follow-up study of adenoviral vector-mediated gene transfer of dopamine d2 receptors in the striatum in young, middle-aged, and aged rats: a positron emission tomography study |
Q37041574 | Loss of D2 dopamine receptor function modulates cocaine-induced glutamatergic synaptic potentiation in the ventral tegmental area |
Q35152033 | Low-dose levodopa protects nerve cells from oxidative stress and up-regulates expression of pCREB and CD39 |
Q35090466 | Lysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs. |
Q42513993 | M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain. |
Q36812804 | MCH and apomorphine in combination enhance action potential firing of nucleus accumbens shell neurons in vitro |
Q35684037 | Male-Specific Alleviation of Iron-Induced Striatal Injury by Inhibition of Autophagy |
Q24655753 | Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex |
Q33206968 | Mechanism of extrasynaptic dopamine signaling in Caenorhabditis elegans |
Q48442724 | Mechanism-based PK-PD model for the prolactin biological system response following an acute dopamine inhibition challenge: quantitative extrapolation to humans. |
Q21131062 | Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neurons |
Q34112855 | Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats |
Q37924629 | Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation. |
Q37330735 | Medial preoptic area interactions with dopamine neural systems in the control of the onset and maintenance of maternal behavior in rats |
Q87074288 | Mediation of dopamine D2 receptors activation in post-conditioning-attenuated cardiomyocyte apoptosis |
Q37268893 | Medical therapy of pituitary adenomas: effects on tumor shrinkage |
Q37331530 | Medication discovery for addiction: translating the dopamine D3 receptor hypothesis |
Q50992294 | Memory re-consolidation and drug conditioning: an apomorphine conditioned locomotor stimulant response can be enhanced or reversed by a single high versus low apomorphine post-trial treatment. |
Q92754815 | Metabolomics for Investigating Physiological and Pathophysiological Processes |
Q37587515 | Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells |
Q27322530 | Methamphetamine and dopamine receptor D1 regulate entrainment of murine circadian oscillators |
Q21132489 | Methamphetamine increases locomotion and dopamine transporter activity in dopamine d5 receptor-deficient mice |
Q38810082 | Methamphetamine-induced psychosis is associated with DNA hypomethylation and increased expression of AKT1 and key dopaminergic genes. |
Q34477911 | MicroRNA 142-3p mediates post-transcriptional regulation of D1 dopamine receptor expression |
Q44931347 | Microdomains for dopamine volume neurotransmission in primate prefrontal cortex. |
Q37050350 | Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet |
Q79453277 | Mitogen-activated protein kinase upregulation reduces renal D1 receptor affinity and G-protein coupling in obese rats |
Q37475667 | Mitragyna speciosa Leaf Extract Exhibits Antipsychotic-Like Effect with the Potential to Alleviate Positive and Negative Symptoms of Psychosis in Mice. |
Q39043093 | Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions. |
Q53209146 | Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: with reference to nervous system. |
Q37140503 | Modification of agonist binding moiety in hybrid derivative 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-1-ol/-2-amino versions: impact on functional activity and selectivity for dopamine D2/D3 receptors |
Q28589976 | Modification of dopamine D(1) receptor knockout phenotype in mice lacking both dopamine D(1) and D(3) receptors |
Q28484537 | Modulation by cocaine of dopamine receptors through miRNA-133b in zebrafish embryos |
Q22253247 | Modulation of dopamine D(2) receptor signaling by actin-binding protein (ABP-280) |
Q44911122 | Modulation of locomotor activity by multiple 5-HT and dopaminergic receptor subtypes in the neonatal mouse spinal cord. |
Q52166599 | Modulation of long-term depression by dopamine in the mesolimbic system. |
Q88425933 | Modulatory effect of dopamine receptor 5 on the neurosecretory Dahlgren cells of the olive flounder, Paralichthys olivaceus |
Q38459199 | Molecular approaches for manipulating astrocytic signaling in vivo. |
Q36137258 | Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse model |
Q33602587 | Molecular cloning and characterization of crustacean type-one dopamine receptors: D1alphaPan and D1betaPan |
Q43086685 | Molecular cloning of bullfrog D2 dopamine receptor cDNA: Tissue distribution of three isoforms of D2 dopamine receptor mRNA. |
Q46690793 | Molecular cloning, expression profile, polymorphism and the genetic effects of the dopamine D1 receptor gene on duck reproductive traits |
Q35856369 | Molecular imaging of cardiovascular gene products |
Q34028189 | Molecular mechanisms of amphetamine actions in Caenorhabditis elegans |
Q37325137 | Molecular mechanisms of psychostimulant-induced structural plasticity |
Q37816579 | Molecular pathways in dystonia |
Q37629974 | Molecular profiling of striatonigral and striatopallidal medium spiny neurons past, present, and future |
Q89313952 | Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences |
Q44371464 | Monoamine reuptake inhibition and mood-enhancing potential of a specified oregano extract |
Q90454187 | Monoaminergic Neuromodulation of Sensory Processing |
Q38930685 | Morphine responsiveness to thermal pain stimuli is aging-associated and mediated by dopamine D1 and D3 receptor interactions |
Q28592237 | Most central nervous system D2 dopamine receptors are coupled to their effectors by Go |
Q35750416 | Multicomponent Synthesis and Biological Evaluation of a Piperazine-Based Dopamine Receptor Ligand Library |
Q24649658 | Multifinality in the development of personality disorders: a Biology x Sex x Environment interaction model of antisocial and borderline traits |
Q37322044 | Multiple roles of Gi/o protein-coupled receptors in control of action potential secretion coupling in pituitary lactotrophs. |
Q32078018 | Negative interaction of dopamine D2 receptor antagonists and GBR 12909 and GBR 12935 dopamine uptake inhibitors in the nucleus accumbens |
Q39770437 | Neural cell adhesion molecule modulates dopaminergic signaling and behavior by regulating dopamine D2 receptor internalization |
Q33227606 | Neuroanatomical phenotyping in the mouse: the dopaminergic system |
Q28748883 | Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate |
Q91991315 | Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse |
Q36756356 | Neurobiology of dopamine in schizophrenia |
Q92822646 | Neurochemical mechanisms for memory processing during sleep: basic findings in humans and neuropsychiatric implications |
Q34000048 | Neurochemical pathways that converge on thalamic trigeminovascular neurons: potential substrate for modulation of migraine by sleep, food intake, stress and anxiety |
Q33688332 | Neurochemistry and defects of biogenic amine neurotransmitter metabolism |
Q82029336 | Neurochemistry of Parkinson's disease |
Q33672256 | Neuroendocrine control by dopamine of teleost reproduction |
Q26864449 | Neuroendocrine immunoregulation in multiple sclerosis |
Q82954939 | Neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice brains |
Q36030702 | Neuroimaging of the dopamine/reward system in adolescent drug use. |
Q26772828 | Neuromodulated Spike-Timing-Dependent Plasticity, and Theory of Three-Factor Learning Rules |
Q47139546 | Neuromodulation of Prefrontal Cortex in Non-Human Primates by Dopaminergic Receptors during Rule-Guided Flexible Behavior and Cognitive Control |
Q28076087 | Neuromodulation of the Feedforward Dentate Gyrus-CA3 Microcircuit |
Q43265388 | Neurons of the dopaminergic/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the trigeminocervical complex: an electrophysiological and immunohistochemical study |
Q38796120 | Neuropeptides and Neurotransmitters That Modulate Thalamo-Cortical Pathways Relevant to Migraine Headache |
Q36931624 | Neuroplasticity of neocortical circuits in schizophrenia. |
Q34366565 | Neuroprotective potential of Bacopa monnieri and Bacoside A against dopamine receptor dysfunction in the cerebral cortex of neonatal hypoglycaemic rats |
Q27024858 | Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment? |
Q28581544 | Neurotensin activates GABAergic interneurons in the prefrontal cortex |
Q30469501 | Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism |
Q37406486 | Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines |
Q39004795 | New Concepts in Dopamine D2 Receptor Biased Signaling and Implications for Schizophrenia Therapy |
Q35178497 | Nigral dopamine loss induces a global upregulation of presynaptic dopamine D1 receptor facilitation of the striatonigral GABAergic output |
Q44334072 | Non-opioid antinociceptive effects of supraspinal histogranin and related peptides: possible involvement of central dopamine D(2) receptor |
Q92131887 | Noncanonical, Dopamine-Dependent Long-Term Potentiation at Hippocampal Output Synapses in a Rodent Model of First-Episode Psychosis |
Q36932540 | Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex |
Q36009882 | Novel approaches to the treatment of cocaine addiction |
Q37970016 | Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop |
Q30413337 | Novel role of sorting nexin 5 in renal D(1) dopamine receptor trafficking and function: implications for hypertension |
Q46835495 | Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds |
Q90396667 | Nucleus accumbens dopamine increases sexual motivation in sexually satiated male rats |
Q53512036 | Nucleus accumbens dopamine receptors mediate hypothalamus-induced antinociception in the rat formalin test. |
Q44624436 | Nucleus accumbens oxytocin and dopamine interact to regulate pair bond formation in female prairie voles |
Q33264987 | Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation |
Q34071860 | Obesity and cortisol |
Q47841860 | Oleic Derivatives of Dopamine and Respiration. |
Q95270474 | Openness to experience predicts dopamine effects on divergent thinking |
Q46876517 | Opposing regulation of pair bond formation by cAMP signaling within the nucleus accumbens shell |
Q38233865 | Orquestic regulation of neurotransmitters on reward-seeking behavior. |
Q37660877 | Outside the box signaling: secreted factors modulate GnRH receptor-mediated gonadotropin regulation |
Q91637248 | Overexpression of a Neuronal Type Adenylyl Cyclase (Type 8) in Sinoatrial Node Markedly Impacts Heart Rate and Rhythm |
Q39875074 | PSD-95 regulates D1 dopamine receptor resensitization, but not receptor-mediated Gs-protein activation |
Q37221338 | PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex |
Q36972523 | Paliperidone and aripiprazole differentially affect the strength of calcium-secretion coupling in female pituitary lactotrophs |
Q48043698 | Paradoxical facilitation after depotentiation protocol can precede dyskinesia onset in early Parkinson's disease. |
Q24300112 | Paralemmin interacts with D3 dopamine receptors: implications for membrane localization and cAMP signaling |
Q78023972 | Partial agonism at serotonin 5-HT1B and dopamine D2L receptors using a luciferase reporter gene assay |
Q34396286 | Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity |
Q42333904 | Peripheral Antinociception Induced by Aripiprazole Is Mediated by the Opioid System. |
Q58606329 | Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis |
Q36339367 | Peripheral chemoreflex inhibition with low-dose dopamine: new insight into mechanisms of extreme apnea. |
Q34970259 | PharmGKB summary: dopamine receptor D2 |
Q37344782 | Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations |
Q40022211 | Pharmacological analysis of human D1 AND D2 dopamine receptor missense variants |
Q50421305 | Pharmacological analysis of zebrafish lphn3.1 morphant larvae suggests that saturated dopaminergic signaling could underlie the ADHD-like locomotor hyperactivity. |
Q44445208 | Pharmacological profile of the vascular responses to dopamine in the canine external carotid circulation. |
Q24623267 | Pharmacological validation of candidate causal sleep genes identified in an N2 cross |
Q28587993 | Phenotypic resolution of spontaneous and D1-like agonist-induced orofacial movement topographies in congenic dopamine D1A receptor 'knockout' mice |
Q36205868 | Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. |
Q44125237 | Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor "knockout". |
Q55420491 | Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson's disease. |
Q35088812 | Pituitary and brain dopamine D2 receptors regulate liver gene sexual dimorphism |
Q54961209 | Pituitary-Directed Therapies for Cushing's Disease. |
Q36812337 | Plasma membrane compartmentalization of D2 dopamine receptors |
Q34264702 | Plasticity in D1-like receptor expression is associated with different components of cognitive processes |
Q37182131 | Plasticity in glutamatergic NTS neurotransmission |
Q49059713 | Polychlorinated biphenyl (PCBs)-induced oxidative stress plays a critical role on cerebellar dopaminergic receptor expression: ameliorative role of quercetin. |
Q43700475 | Polymorphism in exon 6 of the dopamine D(2) receptor gene (DRD2) is associated with elevated blood pressure and personality disorders in men. |
Q35692963 | Positron emission tomography and single photon emission CT molecular imaging in schizophrenia |
Q41998180 | Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist |
Q40550785 | Possible role of the dopamine D1 receptor in the sensorimotor gating deficits induced by high-fat diet |
Q43805049 | Postnatal decrease of sodium current density in rat pituitary melanotropes following the onset of dopaminergic innervation. |
Q34129880 | Potential molecular and cellular mechanism of psychotropic drugs |
Q30408556 | Pre- and Postsynaptic Role of Dopamine D2 Receptor DD2R in Drosophila Olfactory Associative Learning |
Q92532266 | Preclinical PK/PD model for the combinatorial use of dexamethasone and sulpiride in the treatment of breast cancer |
Q36233734 | Predicting childhood effortful control from interactions between early parenting quality and children's dopamine transporter gene haplotypes |
Q86155981 | Predominant role of the dopamine D3 receptor subtype for mediating the quinpirole-induced inhibition of the vasopressor sympathetic outflow in pithed rats |
Q34272454 | Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia |
Q37656934 | Prefrontal Dopaminergic Mechanisms of Extinction in Adolescence Compared to Adulthood in Rats. |
Q34390849 | Prenatal ethanol exposure alters synaptic plasticity in the dorsolateral striatum of rat offspring via changing the reactivity of dopamine receptor |
Q34525825 | Presence and function of dopamine transporter (DAT) in stallion sperm: dopamine modulates sperm motility and acrosomal integrity |
Q45250006 | Presynaptic D1 dopamine receptors in primate prefrontal cortex: target-specific expression in the glutamatergic synapse. |
Q73445715 | Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones |
Q34595068 | Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits |
Q44363749 | Proerectile effects of apomorphine in mice |
Q28506826 | Prolonged fear responses in mice lacking dopamine D1 receptor |
Q46886459 | Prostaglandin E2 acts on EP1 receptor and amplifies both dopamine D1 and D2 receptor signaling in the striatum. |
Q44187993 | Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. |
Q30436711 | Protein kinase A activity controls the regulation of T-type CaV3.2 channels by Gbetagamma dimers |
Q35097990 | Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood |
Q30249553 | Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management |
Q34253250 | Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? |
Q35489276 | Psychostimulants and movement disorders |
Q41271272 | Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain |
Q42244750 | Quantitative comparison of functional screening by measuring intracellular Ca2+ with radioligand binding at recombinant human dopamine receptors |
Q35882042 | Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D₂ receptors in mouse striatum: relation to cannabinoid-1 (CB₁) receptor targeting. |
Q33680404 | Rapid dopaminergic modulation of the fish hypothalamic transcriptome and proteome |
Q38370126 | Recent advances in neuroimaging to model eating disorder neurobiology. |
Q36886717 | Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia |
Q37412106 | Recent molecular approaches to understanding astrocyte function in vivo |
Q44451604 | Receptor mechanisms of prenodal lymphatic constriction by dopamine |
Q44257112 | Receptor subtype-specific modulation by dopamine of glutamatergic responses in striatal medium spiny neurons. |
Q37021538 | Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+,K+-ATPase |
Q24323514 | Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization |
Q36507158 | Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. |
Q34693215 | Reduced threshold for induction of LTP by activation of dopamine D1/D5 receptors at hippocampal CA1-subiculum synapses |
Q58565172 | Regional difference in spontaneous firing inhibition by GABA and GABA receptors in nigral dopamine neurons |
Q40387218 | Regulation of ATP-sensitive potassium channel function by protein kinase A-mediated phosphorylation in transfected HEK293 cells |
Q28512114 | Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo |
Q34990075 | Regulation of dopamine D1 receptor dynamics within the postsynaptic density of hippocampal glutamate synapses |
Q44755344 | Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. |
Q43622959 | Regulation of dopamine D2 receptor expression in grass carp pituitary cells: a possible mechanism for dopaminergic modification of luteinizing hormone synthesis |
Q36208875 | Regulation of glomerulotubular balance. I. Impact of dopamine on flow-dependent transport |
Q39167400 | Regulation of glomerulotubular balance: flow-activated proximal tubule function |
Q92625733 | Regulatory Role of lncRNA NONHSAT089447 in the Dopamine Signaling Pathway in Schizophrenic Patients |
Q35107580 | Regulatory roles of heterogeneous nuclear ribonucleoprotein M and Nova-1 protein in alternative splicing of dopamine D2 receptor pre-mRNA. |
Q46381667 | Repeated cocaine administration induces gene expression changes through the dopamine D1 receptors |
Q45862535 | Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals |
Q26786638 | Research on the effects of integrated resorts in Korea on gambling addiction |
Q37853323 | Resistant prolactinomas |
Q37592449 | Restructuring of basal ganglia circuitry and associated behaviors triggered by low striatal D2 receptor expression: implications for substance use disorders. |
Q36844622 | Rethinking schizophrenia in the context of normal neurodevelopment |
Q36211286 | Reversal of quinpirole inhibition of ventral tegmental area neurons is linked to the phosphatidylinositol system and is induced by agonists linked to G(q). |
Q38233283 | Revision of the classical dopamine D2 agonist pharmacophore based on an integrated medicinal chemistry, homology modelling and computational docking approach. |
Q37318129 | Reward-based hypertension control by a synthetic brain-dopamine interface |
Q35197367 | Role of Beta-arrestin 2 downstream of dopamine receptors in the Basal Ganglia. |
Q92282698 | Role of D3 dopamine receptors in modulating neuroanatomical changes in response to antipsychotic administration |
Q39018562 | Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons |
Q22252576 | Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis |
Q93008187 | Role of Helix 8 in Dopamine Receptor Signaling |
Q33764887 | Role of LRRK2 in the regulation of dopamine receptor trafficking |
Q34633369 | Role of dopamine D2 receptors in ischemia/reperfusion induced apoptosis of cultured neonatal rat cardiomyocytes |
Q34413585 | Role of dopamine D2 receptors in optimizing choice strategy in a dynamic and uncertain environment |
Q38204258 | Role of dopamine in distal retina |
Q34429544 | Roles of dopamine 2 receptor isoforms and g proteins in ethanol regulated prolactin synthesis and lactotropic cell proliferation |
Q24307465 | Roles of protein kinase C and actin-binding protein 280 in the regulation of intracellular trafficking of dopamine D3 receptor |
Q92582599 | Rotigotine Effects on Bladder Function in Patients with Parkinson's Disease |
Q58191870 | Rôle et régulation du récepteur D1 de la dopamine dans le striatum : implications dans les dyskinésies de la maladie de Parkinson |
Q53430499 | SB-334867 (an Orexin-1 Receptor Antagonist) Effects on Morphine-Induced Sensitization in Mice-a View on Receptor Mechanisms. |
Q34490765 | SKF83959, an agonist of phosphatidylinositol-linked D(1)-like receptors, promotes ERK1/2 activation and cell migration in cultured rat astrocytes |
Q26746516 | Safety out of control: dopamine and defence |
Q100494051 | Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator (D1PAM), in Healthy Subjects |
Q82911126 | Scaffold hopping for identification of novel D(2) antagonist based on 3D pharmacophore modelling of illoperidone analogs |
Q28742799 | Schizophrenia: redox regulation and volume neurotransmission |
Q36226814 | Section II. The dopamine system |
Q40624924 | Selection in the dopamine receptor 2 gene: a candidate SNP study |
Q92414811 | Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens |
Q66475902 | Selective D2 receptor PET in manganese-exposed workers. |
Q91854833 | Selective Effects of Thioridazine on Self-Renewal of Basal-Like Breast Cancer Cells |
Q44452908 | Selective alterations of the first NREM sleep cycle in humans by a dopamine D1 receptor antagonist (NNC-687). |
Q41095156 | Selective and interactive effects of D2 receptor antagonism and positive allosteric mGluR4 modulation on waiting impulsivity |
Q52316241 | Selectivity of probes for PET imaging of dopamine D3 receptors. |
Q34294075 | Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system |
Q44782810 | Serotonergic mechanisms of formation of emotional behavior of rats in ontogeny |
Q38223390 | Serotoninergic and dopaminergic modulation of cortico-striatal circuit in executive and attention deficits induced by NMDA receptor hypofunction in the 5-choice serial reaction time task |
Q44028363 | Sex differences in the motor inhibitory and stimulatory role of dopamine D1 receptors in rats |
Q37240139 | Sex differences in the pituitary transforming growth factor-β1 system: studies in a model of resistant prolactinomas |
Q39903468 | Should we be cautious on the use of commercially available antibodies to dopamine receptors? |
Q26738349 | Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacology |
Q28512020 | Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1 |
Q64926088 | Simultaneous Detection of Dopamine and Serotonin-A Comparative Experimental and Theoretical Study of Neurotransmitter Interactions. |
Q43562325 | Site-specific activation of dopamine and serotonin transmission by aniracetam in the mesocorticolimbic pathway of rats |
Q44979386 | Social isolation syndrome in rats. |
Q28645766 | Sodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal control |
Q39024218 | Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas |
Q37222365 | Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome |
Q35216414 | Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways |
Q38122958 | Somatostatin receptors: from signaling to clinical practice |
Q30415400 | Sorting nexin 1 loss results in D5 dopamine receptor dysfunction in human renal proximal tubule cells and hypertension in mice |
Q46127916 | Specific role of dopamine D1 receptors in spinal network activation and rhythmic movement induction in vertebrates |
Q42321220 | Stimulation of adenosine receptors in the nucleus accumbens reverses the expression of cocaine sensitization and cross-sensitization to dopamine D2 receptors in rats |
Q43346674 | Stimulation of dopamine D2-like receptors in the lumbosacral defaecation centre causes propulsive colorectal contractions in rats. |
Q36010682 | Strain dependent gene expression and neurochemical levels in the brain of zebrafish: focus on a few alcohol related targets |
Q30488477 | Strain differences in the expression of dopamine D1 receptors in Wistar-Kyoto (WKY) and Wistar rats |
Q47105024 | Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson's Disease |
Q30443360 | Striatal dopamine D1 receptor is essential for contextual fear conditioning |
Q42119034 | Striatum specific protein, Rhes regulates AKT pathway |
Q37697439 | Structural modifications of neuroprotective anti-Parkinsonian (-)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent mol |
Q38384318 | Structural signatures of DRD4 mutants revealed using molecular dynamics simulations: Implications for drug targeting |
Q37023517 | Structurally constrained hybrid derivatives containing octahydrobenzo[g or f]quinoline moieties for dopamine D2 and D3 receptors: binding characterization at D2/D3 receptors and elucidation of a pharmacophore model. |
Q33828020 | Structure and function of dopamine receptors |
Q52315658 | Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone. |
Q52668422 | Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D2 Dopamine Receptor. |
Q31131022 | Subapical localization of the dopamine D3 receptor in proximal tubules of the rat kidney. |
Q46562595 | Subcellular localization of the dopamine D2 receptor and coexistence with the calcium-binding protein neuronal calcium sensor-1 in the primate prefrontal cortex |
Q40596896 | Subchronic Oral Bromocriptine Methanesulfonate Enhances Open Field Novelty-Induced Behavior and Spatial Memory in Male Swiss Albino Mice |
Q46542145 | Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15. |
Q44308051 | Substance P(1-7) affects the expression of dopamine D2 receptor mRNA in male rat brain during morphine withdrawal |
Q28571468 | Substrate-dependent regulation of MAO-A in rat mesangial cells: involvement of dopamine D2-like receptors |
Q38653197 | Super-resolution Microscopical Localization of Dopamine Receptors 1 and 2 in Rat Hippocampal Synaptosomes. |
Q42759455 | Suppression of dopamine D2-like receptors activates alkaline phosphatase in Drosophila. |
Q47270839 | Survey on basal blood plasma catecholamine concentrations in Martina Franca donkey (Equus asinus). |
Q30360691 | Synaptic control of motoneuronal excitability. |
Q44128178 | Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice |
Q34158231 | Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626. |
Q37286192 | Synthesis and evaluation of ligands for D2-like receptors: the role of common pharmacophoric groups |
Q37380723 | Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates |
Q43801153 | Synthesis of 2-(2,3-dimethoxyphenyl)-4-(aminomethyl)imidazole analogues and their binding affinities for dopamine D(2) and D(3) receptors. |
Q40684888 | Synthesis of 2-(5-bromo-2,3-dimethoxyphenyl)-5-(aminomethyl)-1H-pyrrole analogues and their binding affinities for dopamine D2, D3, and D4 receptors. |
Q43026301 | Synthesis, 3D-QSAR, and structural modeling of benzolactam derivatives with binding affinity for the D(2) and D(3) receptors |
Q41684018 | Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands |
Q26768210 | Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage |
Q28186366 | T-type calcium channel regulation by specific G-protein betagamma subunits |
Q64039259 | TAAR1 levels and sub-cellular distribution are cell line but not breast cancer subtype specific |
Q28588437 | Targeted disruption of the dopamine D(2) and D(3) receptor genes leads to different alterations in the expression of striatal calbindin-D(28k) |
Q30470143 | Targeted mutations in the Na,K-ATPase α 2 isoform confer ouabain resistance and result in abnormal behavior in mice. |
Q27324563 | Targeting neurotransmitter receptors with nanoparticles in vivo allows single-molecule tracking in acute brain slices |
Q36557687 | Targeting the D1-N-methyl-D-aspartate receptor complex reduces L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson's rats |
Q90053610 | Targeting the cholinergic system in Parkinson's disease |
Q27324174 | Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease |
Q30572286 | Test-retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging |
Q28542478 | Tetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegans |
Q50439922 | The Addiction-Related Gene Ankk1 is Oppositely Regulated by D1R- and D2R-Like Dopamine Receptors. |
Q34142339 | The Caenorhabditis elegans D2-like dopamine receptor DOP-2 physically interacts with GPA-14, a Gαi subunit |
Q59809225 | The Contribution of Endogenous Modulatory Systems to TMS- and tDCS-Induced Analgesia: Evidence from PET Studies |
Q51424478 | The D1 dopamine receptor agonist SKF-38393 stimulates the release of glutamate in the hippocampus. |
Q48235496 | The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors |
Q33707895 | The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs |
Q47843837 | The Hypoactivity Associated with the Repeated Exposure to Atrazine Is Related to Decreases in the Specific Binding to D1-DA Receptors in the Striatum of Rats |
Q37111068 | The Islamic Perspective of Spiritual Intervention Effectiveness on Bio-Psychological Health Displayed by Gene Expression in Breast Cancer Patients |
Q61811625 | The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas |
Q37816219 | The Potent Effect of Environmental Context on Relapse to Alcohol-Seeking After Extinction |
Q64929486 | The Prospective Value of Dopamine Receptors on Bio-Behavior of Tumor. |
Q28594205 | The Ras homolog Rhes affects dopamine D1 and D2 receptor-mediated behavior in mice |
Q52564680 | The Relationship Between Dopamine Neurotransmitter Dynamics and the Blood-Oxygen-Level-Dependent (BOLD) Signal: A Review of Pharmacological Functional Magnetic Resonance Imaging. |
Q44614180 | The acute EPS of haloperidol may be unrelated to its metabolic transformation to BCPP + |
Q38691806 | The association between the serotonin and dopamine neurotransmitters and personality traits. |
Q33455500 | The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction |
Q33613625 | The d5 dopamine receptor mediates large-conductance, calcium- and voltage-activated potassium channel activation in human coronary artery smooth muscle cells |
Q80975654 | The differential contribution of dopamine D(1) and D (2) receptors to mu-opioidergic immunomodulation |
Q35786796 | The dopamine D(2) receptor is expressed and sensitizes adenylyl cyclase activity in airway smooth muscle |
Q34193015 | The dopamine D(4) receptor, the ultimate disordered protein |
Q37357146 | The dopamine D1 receptor is expressed and facilitates relaxation in airway smooth muscle |
Q52615455 | The dopamine D1 receptor is expressed and induces CREB phosphorylation and MUC5AC expression in human airway epithelium. |
Q34259695 | The dopamine D2 receptor gene in lamprey, its expression in the striatum and cellular effects of D2 receptor activation |
Q31571349 | The dopamine D2/D3 antagonist DS121 potentiates the effect of cocaine on locomotion and reduces tolerance in cocaine tolerant rats. |
Q51492743 | The dopamine D3 receptor antagonist PNU-99194A fails to block (+)-7-OH-DPAT substitution for D-amphetamine or cocaine. |
Q37694353 | The dopamine D4 receptor: biochemical and signalling properties |
Q46549000 | The dopamine agonism on ADP-stimulated platelets is mediated through D2-like but not D1-like dopamine receptors |
Q21091097 | The dopamine metabolite 3-methoxytyramine is a neuromodulator |
Q52649972 | The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease. |
Q51144688 | The effect and mechanism of dopamine D1 receptors on the proliferation of osteosarcoma cells. |
Q46156558 | The effect of a full agonist/antagonist of the D1 receptor on locomotor activity, sensorimotor gating and cognitive function in dizocilpine-treated rats |
Q43049272 | The effect of dopamine on alkaline phosphatase activity in Drosophila is mediated by D2-like receptors |
Q36797180 | The effects of PRX-07034, a novel 5-HT6 antagonist, on cognitive flexibility and working memory in rats |
Q46610103 | The effects of neurochemical lesioning of dopaminergic terminals in early ontogenesis on behavior in adult rats |
Q34758213 | The evolution of dopamine systems in chordates |
Q38422876 | The extracellular cAMP-adenosine pathway regulates expression of renal D1 dopamine receptors in diabetic rats |
Q33536589 | The genetic effects of the dopamine D1 receptor gene on chicken egg production and broodiness traits |
Q22252519 | The immunoregulatory role of dopamine: an update |
Q38670012 | The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease |
Q28290932 | The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease |
Q34451468 | The neurobiology of pair bonding: Insights from a socially monogamous rodent |
Q37140246 | The neurobiology of social attachment: A comparative approach to behavioral, neuroanatomical, and neurochemical studies |
Q28377105 | The novel antagonist, S33084, and GR218,231 interact selectively with cloned and native, rat dopamine D(3) receptors as compared with native, rat dopamine D(2) receptors |
Q59504815 | The pharmacology of latent inhibition as an animal model of schizophrenia |
Q27027511 | The physiological relevance of functional selectivity in dopamine signalling |
Q34268520 | The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout'). |
Q33327249 | The rate of intravenous cocaine administration alters c-fos mRNA expression and the temporal dynamics of dopamine, but not glutamate, overflow in the striatum |
Q38181840 | The role of D2-autoreceptors in regulating dopamine neuron activity and transmission |
Q52727694 | The role of D2-like receptors in the regulation of juvenile hormone metabolism in Drosophila females in normal state and at increased dopamine level. |
Q30506209 | The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment |
Q53828206 | The role of catecholamines in HIV neuropathogenesis. |
Q37168908 | The role of cyclic nucleotides in pituitary lactotroph functions |
Q41931635 | The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats. |
Q34301403 | The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats |
Q21143767 | The role of dopamine in Drosophila larval classical olfactory conditioning |
Q34425257 | The role of dopamine in reinforcement: changes in reinforcement sensitivity induced by D1-type, D2-type, and nonselective dopamine receptor agonists |
Q28591256 | The role of dopamine receptors in regulating the size of axonal arbors |
Q36627836 | The role of mesocorticolimbic dopamine in regulating interactions between drugs of abuse and social behavior. |
Q26852620 | The role of neuromodulators in selective attention |
Q38208293 | The role of prefrontal catecholamines in attention and working memory |
Q33939097 | The selective vulnerability of striatopallidal neurons |
Q57476258 | The small molecule CA140 inhibits the neuroinflammatory response in wild-type mice and a mouse model of AD |
Q38558097 | The two-century journey of Parkinson disease research |
Q32150534 | The weaver mutant mouse: a model to study the ontogeny of dopamine transmission systems and their role in drug addiction |
Q37438782 | Thyroid hormone and adrenergic signaling interact to control pineal expression of the dopamine receptor D4 gene (Drd4). |
Q46630823 | Tolerance to the procholinergic action of the D1 receptor full agonist dihydrexidine |
Q45178276 | Topographical effects of D1-like dopamine receptor agonists on orofacial movements in mice and their differential regulation via oppositional versus synergistic D1-like: D2-like interactions: cautionary observations on SK&F 82958 as an anomalous age |
Q53539748 | Tracer coupling between fish rod horizontal cells: modulation by light and dopamine but not the retinal circadian clock. |
Q40648976 | Transcriptional Activation of the Human Brain-derived Neurotrophic Factor Gene Promoter III by Dopamine Signaling in NT2/N Neurons |
Q35673749 | Transcriptome response to infraorbital nerve transection in the gonadally intact male rat barrel cortex: RNA-seq |
Q36324194 | Treatment of pituitary tumors: dopamine agonists |
Q37248647 | Unaltered D1, D2, D4, and D5 dopamine receptor mRNA expression and distribution in the spinal cord of the D3 receptor knockout mouse |
Q58758781 | Uncoupling DISC1 × D2R Protein-Protein Interactions Facilitates Latent Inhibition in Disc1-L100P Animal Model of Schizophrenia and Enhances Synaptic Plasticity via D2 Receptors |
Q34152176 | Uncoupling the dopamine D1-D2 receptor complex exerts antidepressant-like effects |
Q48773104 | Uncoupling the dopamine D1-D2 receptor complex: a novel target for antidepressant treatment. |
Q30398918 | Underlying Mechanisms of Gene-Environment Interactions in Externalizing Behavior: A Systematic Review and Search for Theoretical Mechanisms |
Q85310951 | Understanding the Structural Requirements of Hybrid (S)-6-((2-(4-Phenylpiperazin-1-yl)ethyl)(propyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol and its Analogs as D2/D3 Receptor Ligands: A Three-Dimensional Quantitative Structure-Activity Relationship |
Q33922831 | Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation |
Q44275838 | Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatments |
Q36147248 | Use of inotropes and vasopressor agents in critically ill patients. |
Q38669271 | Vagally-mediated effects of brainstem dopamine on gastric tone and phasic contractions of the rat. |
Q57180724 | Validation of gallbladder absorbed radiation dose reduction simulation: human dosimetry of [F]fluortriopride |
Q35647946 | Valproate Inhibits Methamphetamine Induced Hyperactivity via Glycogen Synthase Kinase 3β Signaling in the Nucleus Accumbens Core |
Q43670423 | Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements |
Q45284023 | Voltage-clamp analysis and computational model of dopaminergic neurons from mouse retina |
Q34182721 | Water Extract of Fructus Hordei Germinatus Shows Antihyperprolactinemia Activity via Dopamine D2 Receptor |
Q44058277 | Water permeability of aquaporin-4 is decreased by protein kinase C and dopamine |
Q33702937 | Wfs1 is expressed in dopaminoceptive regions of the amniote brain and modulates levels of D1-like receptors |
Q34721567 | What can we learn from rodents about prolactin in humans? |
Q38335806 | YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice |
Q33915317 | Zebrafish Get Connected: Investigating Neurotransmission Targets and Alterations in Chemical Toxicity |
Q48331506 | c-Fos facilitates the acquisition and extinction of cocaine-induced persistent changes. |
Q41191508 | c-Fos is an intracellular regulator of cocaine-induced long-term changes |
Q34949543 | cAMP level modulates scleral collagen remodeling, a critical step in the development of myopia |
Q48478646 | cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment. |
Q41943753 | mGlu5 Receptor Functional Interactions and Addiction |
Q50527316 | α-Methyltyrosine, a tyrosine hydroxylase inhibitor, decreases stress response in zebrafish (Danio rerio). |
Search more.